Note: Descriptions are shown in the official language in which they were submitted.
CA 02736244 2016-11-24
53645-25
COMPOSITIONS AND METHODS FOR EXPRESSION OF A HETEROLOGOUS
= NUCLEOTIDE SEQUENCE IN PLANTS COMPRISING A
CHLOROPLAST TARGETING PEPTIDE (CTP)
FIELD OF THE INVENTION
The present invention relates to the field of plant molecular biology, more
particularly to the identification and use of regulatory elements in plants.
= BACKGROUND OF THE INVENTION
Chloroplast biogenesis in plants is dependent upon the coordinated activities
of two independent genetic systems localized in the chloroplast and the
nucleus (see
Cline and Henry (1996), Annu. Rev. Cell Dev. Biol. 12, 1-26). The vast
constituent
chloroplast proteins are encoded by the nuclear genes and are synthesized
cytoplasmically- as precursor forms which contain N-terminal extensions known
as
transit peptides. The transit peptide is instrumental for specific recognition
of the
chloroplast surface and in mediating the post-translational translocation of
pre-
proteins across the chloroplast envelope and thence to the various different
subcompartments within the chloroplast (e.g. stroma, thylakoid and thylakoid
membrane).
Genes reported to have naturally encoded transit peptide sequences at their N-
terminus include the chloroplast small subunit of ribulose-1,5-bisphosphate
= carboxylase (RuBisCo), de Castro Silva Filho et al. (1996) Plant Mol.
Biol. 30: 769-
780; Schnell, D. J. et al. (1991) J. Biol. Chem. 266 (5): 3335-3342; 5-
(enolpyruvyl)
shikimate-3-phosphate synthase (EPSPS), Archer et al. (1990) J. Bioenerg. and
Biomemb. 22 (6):789-810; tryptophan synthase. Zhao, J. et al. (1995) J. Biol.
Chem. 2
70 (11):6081-6087; plastocyanin, Lawrence et al. (1997) J. Biol. Chem. 272
.
(33):20357-20363; chorismate synthase, Schmidt et al. (1993) J. Biol. Chem.
268
(36):27477-27457; and the light harvesting chlorophyll a/b binding protein
(LHBP),
Lamppa et al. (1988) J. Biol. Chem. 263: 14996-14999, although not all of
these
sequences have been useful in the heterologous expression of chloroplast-
targeted
proteins in higher plants.
1
CA 02736244 2016-11-24
53645-25
SUMMARY OF INVENTION
Compositions and methods for chloroplast targeting of polypeptides in a plant
are provided. Compositions comprise expression cassettes comprising a
nucleotide sequence
encoding a chloroplast targeting peptide (or chloroplast transit peptide,
"CTP") sequence
derived from an algal organism operably linked to nucleotide sequence of
interest. These
expression constructs are useful for expression and proper targeting of the
nucleotide
sequence of interest in a monocot or a dicot plant. The invention further
provides vectors
comprising the expression cassettes, and plants and plant cells having stably
incorporated or
transiently expressed into their genomes an expression cassette described
above.
Additionally, compositions include transgenic seed of such plants.
Methods are also provided for expressing a nucleotide sequence in a plant or
plant cell, as well as methods for identifying algal CTP sequences for use in
a plant.
In one aspect, there is provided a monocot plant cell having stably
incorporated
into its genome an expression cassette comprising a nucleic acid molecule
comprising a
sequence encoding a chloroplast transit peptide (CTP), wherein said nucleic
acid molecule
comprising the sequence encoding said CTP is operably linked to a nucleic acid
molecule of
interest, and wherein said nucleic acid molecule comprising the sequence
encoding said CTP
is a nucleic acid molecule comprising: a) the nucleotide sequence set forth in
SEQ ID NO:6;
b) a nucleotide sequence having at least 90% sequence identity to SEQ ID NO:6
over the full
length of SEQ ID NO:6, wherein said nucleotide sequence encodes a chloroplast
transit
peptide; c) a fragment of the nucleotide sequences of a) or b), wherein said
fragment encodes
a chloroplast transit peptide; d) a nucleotide sequence encoding the amino
acid sequence set
forth in SEQ ID NO:7; e) a nucleotide sequence encoding an amino acid sequence
having at
least 90% sequence identity to SEQ ID NO:7 over the full length of SEQ ID
NO:7, wherein
said nucleotide sequence encodes a chloroplast transit peptide; or 0 a
nucleotide sequence
encoding a fragment of the amino acid sequence as defined in d) or e), wherein
said
nucleotide sequence encodes a chloroplast transit peptide.
2
CA 02736244 2016-11-24
'
53645-25
In one aspect, there is provided use of a plant comprising the plant cell as
=
described above, for producing seed or a crop.
In one aspect, there is provided a method for expressing a nucleic acid
molecule of interest in a monocot plant, said method comprising: a)
introducing into a plant
cell an expression cassette comprising a nucleic acid molecule comprising a
sequence
encoding a chloroplast transit peptide (CTP), wherein said nucleic acid
molecule comprising
the sequence encoding said CTP is operably linked to said nucleic acid
molecule of interest,
and wherein said nucleic acid molecule comprising the sequence encoding said
CTP is a
nucleic acid molecule comprising: i) the nucleotide sequence set forth in SEQ
ID NO:6; ii) a
nucleotide sequence having at least 90% sequence identity to SEQ ID NO:6 over
the full
length of SEQ ID NO:6, wherein said nucleotide sequence encodes a chloroplast
transit
peptide; iii) a fragment of the nucleotide sequences of i) or ii), wherein
said fragment encodes
a chloroplast transit peptide; iv) a nucleotide sequence encoding the amino
acid sequence set
forth in SEQ ID NO:7; v) a nucleotide sequence encoding an amino acid sequence
having at
least 90% sequence identity to SEQ ID NO:7 over the full length of SEQ ID
NO:7, wherein
said nucleotide sequence encodes a chloroplast transit peptide; or vi) a
nucleotide sequence
encoding a fragment of the amino acid sequence as defined in iv) or v),
wherein said
nucleotide sequence encodes a chloroplast transit peptide; b) regenerating a
transformed plant
from said plant cell; wherein said plant has stably incorporated into its
genome said
expression cassette.
DESCRIPTION OF FIGURES
Figure 1 demonstrates TagGFP expression in tobacco protoplasts.
Figure 2 demonstrates expression and processing of Chlamydornonas EPSPS
chloroplast transit peptide in maize cells. Lane 1: Non-transgenic maize line
Hi-II; .
Lanes 2 - 6: Individual To events transformed with Chlamydomonas EPSPS
CTP/GRG23(ace3)(R173K) construct; Lane 7: Protein molecular weight marker;
Lane 8: Purified GRG23(ace3)(R173K) protein (4 ng).
2a
CA 02736244 2016-11-24
53645-25
Figure 3 demonstrates the calculation of the molecular weight of the processed
Chlamydomonas EPSPS - GRG-23(ace3)(R173K) protein expressed in maize. A linear
regression of the plot of Log Molecular Weight vs. Distance Migration of the
protein
molecular weight standards from Figure 2 was used to calculate the apparent
molecular
weight of the GRG23(ace3)(R173K) protein standard and the processed
Chlamydomonas
EPSPS - GRG-23(ace3)(R173K) detected in plant extract. .
DETAILED DESCRIPTION
In the production of transgenic plants it is often useful to direct foreign
proteins
to specific subcellular locations, e.g., the chloroplast, vacuole,
mitochondria, or ER. Previous
workers have fused DNA sequences encoding transit peptides from various plant
genes to the
genes of interest. When the gene is translated the resulting .
2b
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
protein has the plant transit peptide fused to the amino terminus of the
protein of
interest, and thus the protein is directed, with varying efficiency, to the
desired
subcellular compartment.
Thus, the present invention is drawn to compositions and methods for
chloroplast targeting of polypeptides in higher plants or plant cells. The
compositions
of the present invention comprise expression cassettes comprising a nucleotide
sequence encoding a chloroplast transit peptide (CTP) derived from an algal
organism
operably linked to a nucleotide sequence of interest. In one embodiment, the
CTP is
derived from Chlamydomonas sp. In another embodiment, the CTP comprises the
amino acid sequence set forth in SEQ ID NO:3, 5, or 7 or an amino acid
sequence
encoded by SEQ ID NO:1, 2, 4, or 6, as well as variants, fragments, and
derivatives
thereof In addition, transformed plants, plant cells, and seeds are provided.
The CTP-encoding sequences of the invention, when assembled within a DNA
construct such that the CTP-encoding sequence is operably linked to a
nucleotide
sequence of interest, facilitate co-translational or post-translational
transport of the
peptide of interest to the chloroplast of a plant cell stably transformed with
this DNA
construct. Methods for expressing a nucleotide sequence in a plant comprise
introducing into plant cells an expression cassette comprising a CTP-encoding
nucleotide sequence of the invention operably-linked to a nucleotide sequence
of
interest, and regenerating a transformed plant from the plant cell.
The articles "a" and "an" are used herein to refer to one or more than one
(i.e.,
to at least one) of the grammatical object of the article. By way of example,
"an
element" means one or more elements.
As used herein, the term "nucleic acid molecule" is intended to include DNA
molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and
analogs of the DNA or RNA generated using nucleotide analogs. The nucleic acid
molecule can be single-stranded or double-stranded, but preferably is double-
stranded
DNA.
Chloroplast transit peptides
Chloroplasts are organelles found in plant cells and eukaryotic algae that
conduct photosynthesis. The chloroplast is a complex cellular organelle
composed of
three membranes: the inner envelope membrane, the outer envelope membrane, and
the thylakoid membrane. The membranes together enclose three aqueous
3
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
compartments termed the intermediate space, the stroma, and the thylakoid
lumen.
While chloroplasts contain their own circular genome, many constituent
chloroplast
proteins are encoded by the nuclear genes and are cytoplasmically-synthesized
as
precursor forms which contain N-terminal extensions known as chloroplast
transit
peptides (CTPs). The CTP is instrumental for specific recognition of the
chloroplast
surface and in mediating the post-translational translocation of pre-proteins
across the
chloroplast envelope and into the various different subcompartments within the
chloroplast (e.g. stroma, thylakoid and thylakoid membrane).
At least two distinct functional domains have been identified in chloroplast
transit peptides: the stromal targeting domain (STD) and the lumen targeting
domain
(LTD). STDs govern access to the general import pathway and are both necessary
and
sufficient for import of the passenger protein to the stroma. Stromal protein
precursors
possess transit peptides that contain only an STD, whereas thylakoid lumenal
protein
precursors have both an STD and an LTD.
STDs range in length from about 30 to 120 residues and are rich in
hydroxylated residues and deficient in acidic residues. They tend to share
several
compositional motifs: an amino terminal 10-15 residues devoid of Gly, Pro and
charged residues; a variable middle region rich in Ser, Thr, Lys and Arg; and
a
carboxy-proximal region with loosely conserved sequence (IleNal-X-Ala/Cys-Ala;
SEQ ID NO:17) for proteolytic processing. However, there are no extensive
blocks of
sequence conservation, nor any conserved secondary structural motifs.
Theoretical
analyses suggest that STDs adopt predominantly random coil conformations.
Genes reported to have naturally encoded transit peptide sequences at their N-
terminus include the chloroplast small subunit of ribulose-1,5-bisphosphate
carboxylase (RuBisCo), de Castro Silva Filho et al. (1996) Plant Mol. Biol.
30: 769-
780; Schnell, D. J. et al. (1991) J. Biol. Chem. 266 (5): 3335-3342; 5-
(enolpyruvyl)
shikimate-3-phosphate synthase (EPSPS), Archer et al. (1990) J. Bioenerg. and
Biomemb. 22 (6):789-810; tryptophan synthase. Zhao, J. et al. (1995) J. Biol.
Chem. 2
70 (11):6081-6087; plastocyanin, Lawrence et al. (1997) J. Biol. Chem. 272
(33):20357-20363; chorismate synthase, Schmidt et al. (1993) J. Biol. Chem.
268
(36):27477-27457; and the light harvesting chlorophyll a/b binding protein
(LHBP),
Lamppa et al. (1988) J. Biol. Chem. 263: 14996-14999. Although several CTPS
have
been described, only a few have been utilized successfully in attempts to
target
chimeric molecules to chloroplasts in higher plants.
4
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
The present invention discloses the use of CTPs derived from algal species,
particularly Chlamydomonas sp., in higher plants. For the purposes of the
present
invention, "higher plants" are considered members of the subkingdom
Embryophytae.
In one embodiment, the CTP useful in the methods and compositions disclosed
herein
is derived from Chlamydomonas. In another embodiment, the CTP is set forth in
SEQ
ID NO:3, 5, or 7, or is encoded by SEQ ID NO:1, 2, 4, or 6, including
variants,
fragments, and derivatives thereof. However, one of skill in the art would
understand
how to identify chloroplast transit peptides other than the ones disclosed
herein. For
example, a number of CTPs (or protein sequences comprising CTPs) are listed in
GENBANKO.
The CTPs disclosed herein are useful for targeting a polypeptide to the
chloroplast of a plant cell. In one embodiment, the CTPs disclosed herein
provide
improved translocation compared to CTPs derived from, for example, higher
plant
organisms. The CTPs disclosed herein may result in an at least about 20%, at
least
about 30%, at least about 40%, at least about 50%, at least about 60%, at
least about
70%, at least about 80%, at least about 90%, at least about 100%, or greater,
or at
least about 2-fold, at least about 3-fold, at least about 4-fold, or greater
improvement
in translocation of the polypeptide into the chloroplast when compared to a
reference
CTP. An improvement can be measured in terms of the amount of polypeptide that
gets translocated into the chloroplast, the amount of active polypeptide that
gets
translocated into the chloroplast, or both. An improvement can also be
measured in
terms of an improvement in the phenotype of an organism transformed with the
chloroplast-targeted protein of interest. For example, where the CTP of the
invention
is used to target an herbicide resistance protein to the chloroplast of the
plant, an
improvement in activity can be measured in terms of an improvement in
herbicide
resistance.
Expression cassettes
The CTP-encoding sequences of the invention may be provided in an
expression cassette that allows it to drive expression and localization of a
polypeptide
encoded by the nucleotide sequence of interest into the chloroplast of plant
cells. By
"expression cassette" is intended a DNA construct that is capable of resulting
in the
expression of a protein from an open reading frame in a cell. The cassette
will
include in the 5'-3' direction of transcription, a transcriptional initiation
region
5
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
preferably comprising a promoter suitable for expression in a plant cell of
interest,
operably-linked to a CTP-encoding sequence of the invention, which is further
operably linked to a nucleotide sequence of interest, and a translational and
transcriptional termination region (i.e., termination region) functional in
plants. The
CTP-encoding nucleotide sequence and the nucleotide sequence of interest may
be
separated from one another by nucleotide sequences encoding one or more
"linker"
amino acids as discussed elsewhere herein.
The cassette may additionally contain at least one additional gene to be
cotransformed into the organism, such as a selectable marker gene.
Alternatively, the
additional gene(s) can be provided on multiple expression cassettes. Such an
expression cassette is provided with a plurality of restriction sites for
insertion of the
nucleotide sequence of interest to be under the transcriptional regulation of
the
regulatory regions.
The expression cassette may further comprise 3' and/or 5' untranslated
region(s). By "3' untranslated region" is intended a nucleotide sequence
located
downstream of a coding sequence. Polyadenylation signal sequences and other
sequences encoding regulatory signals capable of affecting the addition of
polyadenylic acid tracts to the 3' end of the mRNA precursor are 3'
untranslated
regions. By "5' untranslated region" is intended a nucleotide sequence located
upstream of a coding sequence. Other upstream or downstream untranslated
elements
include enhancers. Enhancers are nucleotide sequences that act to increase the
expression of a promoter region. Enhancers are well known in the art and
include, but
are not limited to, the 5V40 enhancer region and the 35S enhancer element.
The termination region may be native with the CTP-encoding nucleotide
sequence of the present invention, may be native with the nucleotide sequence
of
interest, or may be derived from another source. Convenient termination
regions are
available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase
and
nopaline synthase termination regions. See also Guerineau et al. (1991) Mol.
Gen.
Genet. 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991)
Genes
Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al.
(1990)
Gene 91:151-158; Ballas et at. (1989) Nucleic Acids Res. 17:7891-7903; and
Joshi et
at. (1987) Nucleic Acid Res. 15:9627-9639.
The expression cassettes described herein may further comprise one or more
regulatory elements other than CTP, as well as additional CTPs known in the
art. By
6
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
"regulatory element" or "regulatory region" is intended a portion of nucleic
acid
found upstream or downstream of a gene, that may be comprised of either DNA or
RNA, or both DNA and RNA and that is involved in gene expression. Regulatory
elements may be capable of mediating organ specificity, or controlling
developmental
or temporal gene activation and include promoter elements, core promoter
elements,
elements that are inducible in response to an external stimulus, elements that
are
activated constitutively, transcriptional terminators, polyadenylation
signals, and
elements that decrease or increase promoter activity such as negative
regulatory
elements or transcriptional enhancers, respectively. By "cis-acting" is
intended a
sequence that is physically contiguous with the transcribed sequence. Cis-
acting
sequences typically interact with proteins or other molecules to carry out
(turn on/off,
regulate, modulate, etc.) transcription. By "transcriptional enhancer" is
intended a
nucleic acid sequence that, when positioned proximate to a promoter and
present in a
transcription medium capable of supporting transcription, confers increased
transcription activity compared to that resulting from the promoter in the
absence of
the enhancer. Enhancers may function upstream, within, or downstream of a
gene,
even as far away as 50 kilobases from the
transcriptional initiation site. Enhancers may also function independently of
their
orientation. By "transcriptional terminator" is intended a DNA sequence that
includes
a nucleotide base pair sequence necessary for reducing or eliminating
transcription.
By "polyadenylation signal" is intended a sequence that controls the
termination of
transcription and translation.
In one aspect of the invention, synthetic DNA sequences are designed for a
given polypeptide, such as the chloroplast-targeted polypeptides useful in the
methods
disclosed herein. Expression of the open reading frame of the synthetic DNA
sequence in a cell results in production of the polypeptide. Synthetic DNA
sequences
can be useful to simply remove unwanted restriction endonuclease recognition
sites,
to facilitate DNA cloning strategies, to alter or remove any potential codon
bias, to
alter or improve GC content, to remove or alter alternate reading frames,
and/or to
alter or remove intron/exon splice recognition sites, polyadenylation sites,
Shine-
Delgarno sequences, unwanted promoter elements and the like that may be
present in
a native DNA sequence. It is also possible that synthetic DNA sequences may be
utilized to introduce other improvements to a DNA sequence, such as
introduction of
an intron sequence, creation of a DNA sequence that in expressed as a protein
fusion
7
CA 02736244 2015-09-17
53645-25
to organelle targeting sequences, such as chloroplast transit peptides,
apoplast/vacuolar targeting peptides, or peptide sequences that result in
retention of
the resulting peptide in the endoplasmic reticulum. Synthetic genes can also
be
synthesized using host cell-preferred codons for improved expression, or may
be
synthesized using codons at a host-preferred codon usage frequency. See, for
example, Campbell and Gown i (1990) Plant Physiol. 92:1-11; U.S. Patent Nos.
6,320,100; 6,075,185; 5,380,831; and 5,436,391, U.S. Published Application
Nos.
20040005600 and 20010003849, and Murray et al. (1989) Nucleic Acids Res.
17:477-
498.
The nucleic acids of interest to be targeted to the chloroplast may also be
optimized for expression in the chloroplast to account for differences in
codon usage
between the plant nucleus and this organelle. In this manner, the nucleic
acids of
interest may be synthesized using chloroplast-preferred codons. See, for
example,
U.S. Patent No. 5,380,831, herein incorporated by reference.
Variants and frag,nents
Nucleic acid molecules that are fragments of the disclosed CTP sequences are
also encompassed by the present invention. By "fragment" is intended a portion
of
the CTP sequence. A fragment of a nucleotide sequence may be biologically
active
and hence be capable of facilitating the translocation of a polypeptide of
interest into
the chloroplast of a plant, or it may be a fragment that can be used as a
hybridization
probe or PCR primer using methods disclosed below. Assays to determine whether
such fragments have CTP activity are well known in the art.
Nucleic acid molecules that are fragments of a CTP-encoding nucleotide
sequence disclosed herein may comprise at least about 90, 100, 125, 150, 175,
200,
225, 250, 275, 300, contiguous nucleotides, or up to the number of nucleotides
present
in a full-length CTP sequence disclosed herein (for example, 306 nucleotides
for SEQ
ID NO:1) depending upon the intended use. By "contiguous" nucleotides is
intended
nucleic acid residues that are immediately adjacent to one another.
Biologically
active fragments of the CTP-encoding sequences of the present invention will
encode
a CTP that retains activity. By "retains CTP activity" is intended that the
fragment
will direct the translocation into the chloroplast of at least about 30%, at
least about
50%, at least about 70%, or at least about 80% of the polypeptide encoded by
the
nucleotide sequence of interest. In one embodiment, a fragment of a CTP-
encoding
8
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
nucleotide sequence disclosed herein may comprise one or more deletions of SEQ
ID
NO:1, 2, 4, or 6, including up to about 2, about 3, about 4, about 5, about 6,
about 7,
about 8, about 9, about 10, about 12, about 15, about 18, about 21, about 24,
about 27,
about 30 or more deletions. In another embodiment, a fragment of a CTP-
encoding
nucleotide sequence disclosed herein may encode an amino acid comprising one
or
more deletions of SEQ ID NO:3, 5, or 7, including up to about 2, about 3,
about 4,
about 5, about 6, about 7, about 8, about 9, about 10 or more amino acid
deletions.
A biologically active portion of a CTP can be prepared by isolating a portion
of one of the CTP sequences of the invention and assessing the activity of
that portion
of the CTP. Methods for measuring CTP activity are well known in the art. See
the
section entitled "Evaluation of CTP Activity" for examples of suitable
methods.
Variants of the CTP-encoding nucleotide sequences or the CTP amino acid
sequences disclosed herein are also encompassed. By "variant" is intended a
sufficiently identical sequence, or a sequence that differs by at least one
amino acid
from a native chloroplast transit peptide. CTP-encoding sequences encompassed
by
the present invention are sufficiently identical to the nucleotide sequence of
SEQ ID
NO:1, 2, 4, or 6. CTP sequences encompassed herein are sufficiently identical
to the
amino acid sequence of SEQ ID NO:3, 5, or 7. By "sufficiently identical" is
intended
a nucleotide sequence that has at least about 70% or 75%, about 80% or 85%
sequence identity, about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99%
sequence identity compared to a reference sequence using one of the alignment
programs as described herein.
In one embodiment, the variants disclosed herein include nucleotide or amino
acid substitutions, deletions, truncations, and insertions of one or more
nucleotides of
SEQ ID NO:1, 2,4, or 6, or one or more amino acids of SEQ ID NO:3, 5, or 7,
including up to about 2, about 3, about 4, about 5, about 6, about 7, about 8,
about 9,
about 10, about 15, about 20, about 25, about 30 or more amino acid
substitutions,
deletions or insertions.
Naturally occurring variants can be identified with the use of well-known
molecular biology techniques, such as polymerase chain reaction (PCR) and
hybridization techniques as outlined below. Variant nucleotide sequences also
include synthetically derived nucleotide sequences that have been generated,
for
example, by using site-directed mutagenesis but which still have CTP activity
as
defined herein.
9
CA 02736244 2011-03-04
WO 2010/028331
PCT/US2009/056165
Variants encompassed by the present invention are biologically active, that is
they continue to possess the desired biological activity of the native
sequence, that is,
retaining CTP activity (i.e., facilitating translocation of the expressed
polypeptide to
the chloroplast). By "retains CTP activity" is intended that the variant will
direct the
translocation to the chloroplast of at least about 30%, at least about 50%, at
least
about 70%, or at least about 80% of the polypeptide encoded by the nucleotide
sequence of interest. Methods for measuring CTP activity are well known in the
art.
See the section entitled "Evaluation of CTP Activity" for examples of suitable
methods.
The skilled artisan will further appreciate that changes to the CTP can be
introduced by mutation into the nucleotide sequence encoding the CTPs of the
invention without altering the ability of the CTP to drive translocation of a
polypeptide in the chloroplast of a plant cell. Thus, variant isolated nucleic
acid
molecules can be created by introducing one or more nucleotide substitutions,
additions, or deletions into the corresponding nucleotide sequence disclosed
herein.
Mutations can be introduced by standard techniques, such as site-directed
mutagenesis and PCR-mediated mutagenesis. Such variant nucleotide sequences
are
also encompassed by the present invention.
Alternatively, variant nucleotide sequences can be made by introducing
mutations randomly along all or part of the CTP sequence, such as by
saturation
mutagenesis, and the resultant mutants can be screened for ability to drive
translocation of an operably linked polypeptide sequence into the chloroplast
a plant
cell.
By "operably linked" is intended a functional linkage between a regulatory
element (e.g., a CTP) and a second sequence, wherein the CTP sequence directs
the
translocation of the polypeptide of interest to the chloroplast of a plant
cell.
Generally, but not always, operably linked means that the nucleic acid
sequences
being linked are contiguous and, where necessary to join two protein coding
regions,
contiguous and in the same reading frame.
To determine the percent identity of two nucleic acids, the sequences are
aligned for optimal comparison purposes. The percent identity between the two
sequences is a function of the number of identical positions shared by the
sequences
(i.e., percent identity = number of identical positions/total number of
positions (e.g.,
overlapping positions) x 100). In one embodiment, the two sequences are the
same
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
length. In another embodiment, the comparison is across the entirety of the
reference
sequence (e.g., SEQ ID NO:1, 2, 4, or 6). The percent identity between two
sequences
can be determined using techniques similar to those described below, with or
without
allowing gaps. In calculating percent identity, typically exact matches are
counted.
The determination of percent identity between two sequences can be
accomplished using a mathematical algorithm. A nonlimiting example of a
mathematical algorithm utilized for the comparison of two sequences is the
algorithm
of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 87:2264, modified as
in
Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877. Such an
algorithm is incorporated into the BLASTN program of Altschul et at. (1990)J.
Mol.
Biol. 215:403. BLAST nucleotide searches can be performed with the BLASTN
program, score = 100, wordlength = 12, to obtain nucleotide sequences
homologous
to sequences of the invention. To obtain gapped alignments for comparison
purposes,
Gapped BLAST can be utilized as described in Altschul et at. (1997) Nucleic
Acids
Res. 25:3389. Alternatively, PSI-Blast can be used to perform an iterated
search that
detects distant relationships between molecules. See Altschul et at. (1997)
supra.
When utilizing BLAST, Gapped BLAST, and PSI-Blast programs, the default
parameters of the respective programs (e.g., BLASTN) can be used. See,
www.ncbi.nlm.nih.gov. Another non-limiting example of a mathematical algorithm
utilized for the comparison of sequences is the ClustalW algorithm (Higgins et
at.
(1994) Nucleic Acids Res. 22:4673-4680). ClustalW compares sequences and
aligns
the entirety of the DNA sequence, and thus can provide data about the sequence
conservation of the entire nucleotide sequence. The ClustalW algorithm is used
in
several commercially available DNA analysis software packages, such as the
ALIGNX module of the vector NTi Program Suite (Informax, Inc). A non-limiting
example of a software program useful for analysis of ClustalW alignments is
GeneDocTM. GenedocTM (Karl Nicholas) allows assessment of DNA similarity and
identity between multiple genes. Another preferred, non-limiting example of a
mathematical algorithm utilized for the comparison of sequences is the
algorithm of
Myers and Miller (1988) CABIOS 4:11-17. Such an algorithm is incorporated into
the
ALIGN program (version 2.0), which is part of the GCG sequence alignment
software
package (available from Accelrys, Inc., 9865 Scranton Rd., San Diego,
California,
USA).
11
CA 02736244 2015-09-17
53645-25
Unless otherwise stated, GAP Version 10, which uses the algorithm of
Needleman and Wunsch (1970)1 MoL Biol. 48(3):443-453, will be used to
determine
sequence identity or similarity using the following parameters: % identity and
%
similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight
of 3,
and the nwsgapdna.cmp scoring matrix; % identity or % similarity for an amino
acid
sequence using GAP weight of 8 and length weight of 2, and the BLOSUM62
scoring
program. Equivalent programs may also be used. By "equivalent program" is
intended any sequence comparison program that, for any two sequences in
question,
generltes an alignment having identical nucleotide residue matches and an
identical
percent sequence identity when compared to the corresponding alignment
generated
by GAP Version 10.
Using methods such as PCR, hybridization, and the like, corresponding
sequences from other organisms, particularly other algal organisms, can be
identified,
such sequences having substantial identity to the sequences of the invention.
See, for
example, Sambrook J., and Russell, D.W. (2001) Molecular Cloning: A Laboratory
Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) and
Innis,
et al. (1990) PCR Protocols: A Guide to Methods and Applications (Academic
Press,
NY). Sequences identified by their identity to the CTP sequences set forth
herein are
encompassed by the present invention.
In another embodiment, CTPs can be identified based on the identification of
sequences known to comprise CTPs. For example, chloroplast-targeted sequences
can be identified based on similarity to the chloroplast-targeted proteins
disclosed
herein or known in the art (e.g., acetolactate synthase (AHAS), small subunit
(SSU),
and EPSPS). The CTP sequence from these targeted proteins can be identified
using
methods known in the art. See, for example, Emanuelsson and von Heijne (2001)
Biochimica et Biophysica Acta 1541:114-119; Nielson et al. (1997) Protein Eng.
10:1-6; and, Nielson and Krogh (1998) IntelL S:yst. Mol. Biol. 6:122-130.
A variety of computer
programs are also available for identifying. See, for example, ChloroP (which
can be
found at the intern& address www.cbs.dtu.dk/services/ChloroP/); Predotar
(which
can be found at the interne address www.inra.fr/Internet/Produits/Predotar/);
and,
SignalP (which can be found at the interne address
www.cbs.dtu.dleservices/SignalP/).
12
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
Oligonucleotide primers can be designed for use in PCR reactions to amplify
corresponding DNA sequences from cDNA or genomic DNA from an organism of
interest. Methods for designing PCR primers and PCR cloning are generally
known in
the art and are disclosed in Sambrook et al. (1989) Molecular Cloning: A
Laboratory
Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
See
also Innis et al., eds. (1990) PCR Protocols: A Guide to Methods and
Applications
(Academic Press, New York); Innis and Gelfand, eds. (1995) PCR Strategies
(Academic Press, New York); and Innis and Gelfand, eds. (1999) PCR Methods
Manual (Academic Press, New York). Known methods of PCR include, but are not
limited to, methods using paired primers, nested primers, single specific
primers,
degenerate primers, gene-specific primers, vector-specific primers, and
partially-
mismatched primers.
In a hybridization method, all or part of a known nucleotide sequence can be
used to screen cDNA or genomic libraries. Methods for construction of such
cDNA
and genomic libraries are generally known in the art and are disclosed in
Sambrook
and Russell, 2001, supra. The hybridization probes may be genomic DNA
fragments,
cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled
with
a detectable group such as 32P, or any other detectable marker, such as other
radioisotopes, a fluorescent compound, an enzyme, or an enzyme co-factor.
Probes
for hybridization can be made by labeling synthetic oligonucleotides based on
the
known CTP-encoding sequence disclosed herein or primers to the known
chloroplast
targeted protein. Degenerate primers designed on the basis of conserved
nucleotides
in the nucleotide sequence can additionally be used. The probe typically
comprises a
region of nucleotide sequence that hybridizes under stringent conditions to at
least
about 12, at least about 20, at least about 25, 30, 35, 40, 45, 50, 55, 60,
75, 100, 125,
150, 175, 200, 250, 300, 350, or 400 consecutive nucleotides of the CTP-
encoding
sequence of the invention, a nucleotide sequence encoding a chloroplast
targeted
protein, or a fragment or variant thereof Preparation of probes for
hybridization is
generally known in the art and is disclosed in Sambrook and Russell, 2001,
supra,
herein incorporated by reference.
For example, the entire CTP-encoding sequence disclosed herein (or coding
sequence for chloroplast-targeted protein), or one or more portions thereof,
may be
used as a probe capable of specifically hybridizing to corresponding CTP-like
sequences. To achieve specific hybridization under a variety of conditions,
such
13
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
probes include sequences that are unique and are at least about 10 nucleotides
in
length, or at least about 20 nucleotides in length. Such probes may be used to
amplify
corresponding CTP-encoding sequences from a chosen organism by PCR. This
technique may be used to isolate additional coding sequences from a desired
organism
or as a diagnostic assay to determine the presence of coding sequences in an
organism. Hybridization techniques include hybridization screening of plated
DNA
libraries (either plaques or colonies; see, for example, Sambrook et at.
(1989)
Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY).
Hybridization of such sequences may be carried out under stringent
conditions. By "stringent conditions" or "stringent hybridization conditions"
is
intended conditions under which a probe will hybridize to its target sequence
to a
detectably greater degree than to other sequences (e.g., at least 2-fold over
background). Stringent conditions are sequence-dependent and will be different
in
different circumstances. By controlling the stringency of the hybridization
and/or
washing conditions, target sequences that are 100% complementary to the probe
can
be identified (homologous probing). Alternatively, stringency conditions can
be
adjusted to allow some mismatching in sequences so that lower degrees of
similarity
are detected (heterologous probing). Generally, a probe is less than about
1000
nucleotides in length, or less than 500 nucleotides in length.
Typically, stringent conditions will be those in which the salt concentration
is
less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion
concentration (or
other salts) at pH 7.0 to 8.3 and the temperature is at least about 30 C for
short probes
(e.g., 10 to 50 nucleotides) and at least about 60 C for long probes (e.g.,
greater than
50 nucleotides). Stringent conditions may also be achieved with the addition
of
destabilizing agents such as formamide. Exemplary low stringency conditions
include hybridization with a buffer solution of 30 to 35% formamide, 1 M NaC1,
1%
SDS (sodium dodecyl sulfate) at 37 C, and a wash in 1X to 2X SSC (20X SSC =
3.0
M NaC1/0.3 M trisodium citrate) at 50 to 55 C. Exemplary moderate stringency
conditions include hybridization in 40 to 45% formamide, 1.0 M NaC1, 1% SDS at
37 C, and a wash in 0.5X to 1X SSC at 55 to 60 C. Exemplary high stringency
conditions include hybridization in 50% formamide, 1 M NaC1, 1% SDS at 37 C,
and
a wash in 0.1X SSC at 60 to 65 C. Optionally, wash buffers may comprise about
14
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
0.1% to about 1% SDS. Duration of hybridization is generally less than about
24
hours, usually about 4 to about 12 hours. Optionally, wash buffers may
comprise
about 0.1% to about 1% SDS.
Specificity is typically the function of post-hybridization washes, the
critical
factors being the ionic strength and temperature of the final wash solution.
For DNA-
DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl
(1984) Anal. Biochem. 138:267-284: Tm = 81.5 C + 16.6 (log M) + 0.41 (%GC) -
0.61 (% form) - 500/L; where M is the molarity of monovalent cations, %GC is
the
percentage of guanosine and cytosine nucleotides in the DNA, % form is the
percentage of formamide in the hybridization solution, and L is the length of
the
hybrid in base pairs. The Tm is the temperature (under defined ionic strength
and pH)
at which 50% of a complementary target sequence hybridizes to a perfectly
matched
probe. Tm is reduced by about 1 C for each 1% of mismatching; thus, Tm,
hybridization, and/or wash conditions can be adjusted to hybridize to
sequences of the
desired identity. For example, if sequences with >90% identity are sought, the
Tm can
be decreased 10 C. Generally, stringent conditions are selected to be about 5
C lower
than the thermal melting point (Tm) for the specific sequence and its
complement at a
defined ionic strength and pH. However, severely stringent conditions can
utilize a
hybridization and/or wash at 1, 2, 3, or 4 C lower than the thermal melting
point (Tm);
moderately stringent conditions can utilize a hybridization and/or wash at 6,
7, 8, 9, or
10 C lower than the thermal melting point (Tm); low stringency conditions can
utilize
a hybridization and/or wash at 11, 12, 13, 14, 15, or 20 C lower than the
thermal
melting point (Tm). Using the equation, hybridization and wash compositions,
and
desired Tm, those of ordinary skill will understand that variations in the
stringency of
hybridization and/or wash solutions are inherently described. If the desired
degree of
mismatching results in a Tm of less than 45 C (aqueous solution) or 32 C
(formamide
solution), the SSC concentration can be increased so that a higher temperature
can be
used. An extensive guide to the hybridization of nucleic acids is found in
Tijssen
(1993) Laboratory Techniques in Biochemistry and Molecular Biology-
Hybridization with Nucleic Acid Probes, Part I, Chapter 2 (Elsevier, New
York); and
Ausubel et al., eds. (1995) Current Protocols in Molecular Biology, Chapter 2
(Greene Publishing and Wiley-Interscience, New York). See Sambrook et al.
(1989)
Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY).
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
Isolated sequences that have CTP activity and which hybridize under stringent
conditions to the CTP sequences disclosed herein, or to fragments thereof, are
encompassed by the present invention.
Methods of Use
Methods of the present invention are directed to the proper expression,
translocation, and processing of chloroplast-targeted sequences in higher
plants and
plant cells under the control of the CTP sequences of the present invention.
For the
purposes of the present invention, a "processed" chloroplast targeted protein
is one in
which the CTP has been removed. At the time of translocation of a chloroplast
targeted protein into the chloroplast of a plant cell, the CTP is removed from
targeted
protein by cleavage at a particular "cleavage site" between the CTP and the
mature
protein. The cleavage site can be determined experimentally, or may be
predicted
based on sequence structure (e.g., by alignment of the unprocessed protein
with
chloroplast targeted proteins in which the cleavage site is known, by
analyzing the
sequence for the presence of characteristic CTP domains, and the like) or by
using
one or more algorithms for cleavage site prediction as discussed elsewhere
herein
(e.g., SignalP).
The transgenic plants may have a change in phenotype, including, but not
limited to, an altered pathogen or insect defense mechanism, an increased
resistance
to one or more herbicides, an increased ability to withstand stressful
environmental
conditions, a modified ability to produce starch, a modified level of starch
production,
a modified oil content and/or composition, a modified ability to utilize,
partition
and/or store nitrogen, and the like. These results can be achieved through the
expression and targeting of a polypeptide of interest to chloroplasts in
plants, wherein
the polypeptide of interest functions in the chloroplast. The CTP sequences of
the
invention are useful for targeting native sequences as well as heterologous
(non-
native) sequences in higher plants. For the purposes of the present invention,
"higher
plants" are considered members of the subkingdom Embryophytae. In one
embodiment, the plant is a monocotyledon. In another embodiment, the plant is
a
dicotyledon.
Generally, the nucleotide sequence encoding the CTP of the invention is
provided in an expression cassette with a nucleotide sequence of interest for
expression in the plant of interest. In one embodiment, the CTP-encoding
sequences
16
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
of the invention are useful for the improved translocation of native sequences
in a
plant. In other embodiments, the CTP-encoding sequences are useful for
expression
and translocation of polypeptides encoded by heterologous nucleotide
sequences. By
"heterologous nucleotide sequence" is intended a sequence that is not
naturally
operably-linked with the CTP-encoding sequence of the invention, including non-
naturally occurring multiple copies of a naturally occurring DNA sequence.
While
this nucleotide sequence is heterologous to the CTP-encoding sequence, it may
be
homologous, or "native," or heterologous, or "foreign," to the plant host. In
some
cases, the transformed plant may have a change in phenotype. "Heterologous"
generally refers to the nucleic acid sequences that are not endogenous to the
cell or
part of the native genome in which they are present, and have been added to
the cell
by infection, transfection, microinjection, electroporation, microprojection,
or the like.
Any nucleotide sequence of interest may be used with the CTP-encoding
sequences of the invention, so long as the polypeptide encoded by the
nucleotide
sequence of interest (i.e., the "polypeptide of interest") is functional in a
chloroplast.
Such nucleotide sequences include, but are not limited to, herbicide-tolerance
coding
sequences, insecticidal coding sequences, nematicidal coding sequences,
antimicrobial coding sequences, antifungal coding sequences, antiviral coding
sequences, abiotic and biotic stress tolerance coding sequences, or sequences
modifying plant traits such as yield, grain quality, nutrient content, starch
quality and
quantity, nitrogen fixation and/or utilization, and oil content and/or
composition.
More specific genes of interest for the present invention include, but are not
limited
to, genes that improve crop yield, genes that improve desirability of crops,
genes
encoding proteins conferring resistance to abiotic stress, such as drought,
temperature,
salinity, toxic metals or trace elements, or those conferring resistance to
toxins such as
pesticides and herbicides, or to biotic stress, such as attacks by fungi,
viruses,
bacteria, insects, and nematodes, and development of diseases associated with
these
organisms. It is recognized that any gene of interest can be operably linked
to the
CTP-encoding sequences of the invention and expressed in a plant, so long as
the
polypeptide encoded by the gene is functional in chloroplasts.
These nucleotide sequences of interest may encode proteins involved in
providing disease or pest resistance. By "disease resistance" or "pest
resistance" is
intended that the plants avoid the harmful symptoms that are the outcome of
the plant-
pathogen interactions. Disease resistance and insect resistance genes such as
17
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
lysozymes or cecropins for antibacterial protection, or proteins such as
defensins,
glucanases or chitinases for antifungal protection, or Bacillus thuringiensis
endotoxins, protease inhibitors, collagenases, lectins, or glycosidases for
controlling
nematodes or insects are all examples of useful gene products. Examples of
genes of
interest may be found, for example, at
www.nbiap.vt.edu/cfdocs/fieldtests2.cfin.
"Pest" includes, but is not limited to, insects, fungi, bacteria, viruses,
nematodes, mites, ticks, and the like. Insect pests include insects selected
from the
orders Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera,
Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura,
Siphonaptera, Trichoptera, etc., particularly Coleoptera, Lepidoptera, and
Diptera.
Viruses include but are not limited to tobacco or cucumber mosaic virus,
ringspot
virus, necrosis virus, maize dwarf mosaic virus, etc. Nematodes include but
are not
limited to parasitic nematodes such as root knot, cyst, and lesion nematodes,
including
Heterodera spp., Meloidogyne spp., and Globodera spp.; particularly members of
the
cyst nematodes, including, but not limited to, Heterodera glycines (soybean
cyst
nematode); Heterodera schachtii (beet cyst nematode); Heterodera avenae
(cereal
cyst nematode); and Globodera rostochiensis and Globodera pailida (potato cyst
nematodes). Lesion nematodes include but are not limited to Pratylenchus spp.
Fungal pests include those that cause leaf, yellow, stripe and stem rusts.
An "herbicide resistance protein" or a protein resulting from expression of an
"herbicide resistance-encoding nucleic acid molecule" includes proteins that
confer
upon a cell the ability to tolerate a higher concentration of an herbicide
than cells that
do not express the protein, or to tolerate a certain concentration of an
herbicide for a
longer period of time than cells that do not express the protein. Herbicide
resistance
traits may be introduced into plants by genes coding for resistance to
herbicides that
act to inhibit the action of acetolactate synthase (ALS), in particular the
sulfonylurea-
type herbicides, genes coding for resistance to herbicides that act to inhibit
the action
of glutamine synthase, such as phosphinothricin or basta (e.g., the bar gene),
glyphosate (e.g., the EPSP synthase gene and the GAT gene) or other such genes
known in the art.
Genes that improve crop yield include dwarfing genes, such as Rhtl and Rht2
(Peng et al. (1999) Nature 400:256-261), and those that increase plant growth,
such as
ammonium-inducible glutamate dehydrogenase. Genes that improve desirability of
crops include, for example, those that allow plants to have a reduced
saturated fat
18
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
content, those that boost the nutritional value of plants, and those that
increase grain
protein. Genes that improve salt tolerance are those that increase or allow
plant
growth in an environment of higher salinity than the native environment of the
plant
into which the salt-tolerant gene(s) has been introduced.
Plant transformation vectors
Typically the plant expression cassette will be inserted into a "plant
transformation vector." By "transformation vector" is intended a DNA molecule
that
is necessary for efficient transformation of a cell. Such a molecule may
consist of one
or more expression cassettes, and may be organized into more than one "vector"
DNA
molecule. For example, binary vectors are plant transformation vectors that
utilize
two non-contiguous DNA vectors to encode all requisite cis- and trans-acting
functions for transformation of plant cells (Hellens and Mullineaux (2000)
Trends in
Plant Science 5:446-451). "Vector" refers to a nucleic acid construct designed
for
transfer between different host cells. "Expression vector" refers to a vector
that has
the ability to incorporate, integrate and express heterologous DNA sequences
or
fragments in a foreign cell. By "introducing" is intended to present to the
organism
being transformed the nucleotide construct in such a manner that the construct
gains
access to the interior of at least one cell of the organism.
This plant transformation vector may be comprised of one or more DNA
vectors needed for achieving plant transformation. For example, it is a common
practice in the art to utilize plant transformation vectors that are comprised
of more
than one contiguous DNA segment. These vectors are often referred to in the
art as
'binary vectors'. Binary vectors as well as vectors with helper plasmids are
most
often used for Agrobacterium-mediated transformation, where the size and
complexity of DNA segments needed to achieve efficient transformation is quite
large, and it is advantageous to separate functions onto separate DNA
molecules.
Binary vectors typically contain a plasmid vector that contains the cis-acting
sequences required for T-DNA transfer (such as left border and right border),
a
selectable marker that is engineered to be capable of expression in a plant
cell, and a
"gene of interest" (a gene engineered to be capable of expression in a plant
cell for
which generation of transgenic plants is desired). Also present on this
plasmid vector
are sequences required for bacterial replication.
19
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
The cis-acting sequences are arranged in a fashion to allow efficient transfer
into plant cells and expression therein. For example, the selectable marker
gene and
the gene of interest are located between the left and right borders. Often a
second
plasmid vector contains the trans-acting factors that mediate T-DNA transfer
from
Agrobacterium to plant cells. This plasmid often contains the virulence
functions (Vir
genes) that allow infection of plant cells by Agrobacterium, and transfer of
DNA by
cleavage at border sequences and vir-mediated DNA transfer, as in understood
in the
art (Hellens and Mullineaux (2000) Trends in Plant Science, 5:446-451).
Several
types of Agrobacterium strains (e.g. LBA4404, GV3101, EHA101, EHA105, etc.)
can
be used for plant transformation. The second plasmid vector is not necessary
for
transforming the plants by other methods such as microprojection,
microinjection,
electroporation, polyethylene glycol, etc.
Plant Transformation
Methods of the invention involve introducing a nucleotide construct into a
plant. By "introducing" is intended to present to the plant the nucleotide
construct in
such a manner that the construct gains access to the interior of a cell of the
plant. The
methods of the invention do not require that a particular method for
introducing a
nucleotide construct to a plant is used, only that the nucleotide construct
gains access
to the interior of at least one cell of the plant. Methods for introducing
nucleotide
constructs into plants are known in the art including, but not limited to,
stable
transformation methods, transient transformation methods, and virus-mediated
methods.
Transformation of plant cells can be accomplished by one of several
techniques known in the art. By "plant" is intended whole plants, plant organs
(e.g.,
leaves, stems, roots, etc.), seeds, plant cells, propagules, embryos and
progeny of the
same. Plant cells can be differentiated or undifferentiated (e.g. callus,
suspension
culture cells, protoplasts, leaf cells, root cells, phloem cells, pollen).
"Transgenic
plants" or "transformed plants" or "stably transformed" plants or cells or
tissues refer
to plants that have incorporated or integrated exogenous nucleic acid
sequences or
DNA fragments into the plant cell. By "stable transformation" is intended that
the
nucleotide construct introduced into a plant integrates into the genome of the
plant
and is capable of being inherited by progeny thereof
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
In general, plant transformation methods involve transferring heterologous
DNA into target plant cells (e.g. immature or mature embryos, suspension
cultures,
undifferentiated callus, protoplasts, etc.), followed by applying a maximum
threshold
level of appropriate selection (depending on the selectable marker gene) to
recover the
transformed plant cells from a group of untransformed cell mass. Explants are
typically transferred to a fresh supply of the same medium and cultured
routinely.
Subsequently, the transformed cells are differentiated into shoots after
placing on
regeneration medium supplemented with a maximum threshold level of selecting
agent. The shoots are then transferred to a selective rooting medium for
recovering
rooted shoot or plantlet. The transgenic plantlet then grow into mature plant
and
produce fertile seeds (e.g. Hiei et al. (1994) The Plant Journal 6:271-282;
Ishida et al.
(1996) Nature Biotechnology 14:745-750). A general description of the
techniques
and methods for generating transgenic plants are found in Ayres and Park
(1994)
Critical Reviews in Plant Science 13:219-239 and Bommineni and Jauhar (1997)
Maydica 42:107-120. Since the transformed material contains many cells; both
transformed and non-transformed cells are present in any piece of subjected
target
callus or tissue or group of cells. The ability to kill non-transformed cells
and allow
transformed cells to proliferate results in transformed plant cultures. Often,
the ability
to remove non-transformed cells is a limitation to rapid recovery of
transformed plant
cells and successful generation of transgenic plants. Molecular and
biochemical
methods may be used to confirm the presence of the integrated heterologous
gene of
interest in the genome of transgenic plant.
Generation of transgenic plants may be performed by one of several methods,
including, but not limited to, introduction of heterologous DNA by
Agrobacterium
into plant cells (Agrobacterium-mediated transformation), bombardment of plant
cells
with heterologous foreign DNA adhered to particles, and various other non-
particle
direct-mediated methods (e.g. Hiei et al. (1994) The Plant Journal 6:271-282;
Ishida
et al. (1996) Nature Biotechnology 14:745-750; Ayres and Park (1994) Critical
Reviews in Plant Science 13:219-239; Bommineni and Jauhar (1997) Maydica
42:107-120) to transfer DNA.
Methods for transformation of chloroplasts are known in the art. See, for
example, Svab et al. (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530; Svab and
Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Svab and Maliga (1993)
EMBO J. 12:601-606. The method relies on particle gun delivery of DNA
containing
21
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
a selectable marker and targeting of the DNA to the plastid genome through
homologous recombination. Additionally, plastid transformation can be
accomplished by transactivation of a silent plastid-borne transgene by tissue-
preferred
expression of a nuclear-encoded and plastid-directed RNA polymerase. Such a
system has been reported in McBride et at. (1994) Proc. Natl. Acad. Sci. USA
91:7301-7305.
The cells that have been transformed may be grown into plants in accordance
with conventional ways. See, for example, McCormick et at. (1986) Plant Cell
Reports 5:81-84. These plants may then be grown, and either pollinated with
the
same transformed strain or different strains, and the resulting hybrid having
constitutive expression of the desired phenotypic characteristic identified.
Two or
more generations may be grown to ensure that expression of the desired
phenotypic
characteristic is stably maintained and inherited and then seeds harvested to
ensure
expression of the desired phenotypic characteristic has been achieved. In this
manner,
the present invention provides transformed seed (also referred to as
"transgenic seed")
having a nucleotide construct of the invention, for example, an expression
cassette of
the invention, stably incorporated into their genome.
Plants
The present invention may be used for transformation of any higher plant
species, including, but not limited to, monocots and dicots. In one
embodiment, the CTP
encompassed herein is active in both monocots and dicots. In another
embodiment, the
CTP is active only in monocots or only in dicots. Examples of plants of
interest include,
but are not limited to, corn (maize), sorghum, wheat, sunflower, tomato,
crucifers,
peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley,
and
oilseed rape, Brassica sp., alfalfa, rye, millet, safflower, peanuts, sweet
potato, cassava,
coffee, coconut, pineapple, citrus trees, cocoa, tea, banana, avocado, fig,
guava, mango,
olive, papaya, cashew, macadamia, almond, oats, vegetables, ornamentals, and
conifers.
Vegetables include, but are not limited to, tomatoes, lettuce, green beans,
lima
beans, peas, and members of the genus Curcumis such as cucumber, cantaloupe,
and
musk melon. Ornamentals include, but are not limited to, azalea, hydrangea,
hibiscus,
roses, tulips, daffodils, petunias, carnation, poinsettia, and chrysanthemum.
Preferably,
22
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
plants of the present invention are crop plants (for example, maize, sorghum,
wheat,
sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean,
sugarbeet,
sugarcane, tobacco, barley, oilseed rape, etc.).
This invention is particularly suitable for any member of the monocot plant
family including, but not limited to, maize, rice, barley, oats, wheat,
sorghum, rye,
sugarcane, pineapple, yams, onion, banana, coconut, and dates.
Evaluation of Plant Transformation
Following introduction of heterologous foreign DNA into plant cells, the
transformation or integration of heterologous DNA in the plant genome is
confirmed
by various methods such as analysis of nucleic acids or proteins and
metabolites
associated with the integrated DNA.
PCR analysis is a rapid method to screen transformed cells, tissue or shoots
for
the presence of incorporated DNA at the earlier stage before transplanting
into the soil
(Sambrook and Russell, 2001. Molecular Cloning: A Laboratory Manual. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY). PCR is carried out
using
oligonucleotide primers specific to the gene of interest or Agrobacterium
vector
background, etc.
Plant transformation may be confirmed by Southern blot analysis of genomic
DNA (Sambrook and Russell, 2001, supra). In general, total DNA is extracted
from
the transformant, digested with appropriate restriction enzymes, fractionated
in an
agarose gel and transferred to a nitrocellulose or nylon membrane. The
membrane or
"blot" then is probed with, for example, radiolabeled 32P target DNA fragment
to
confirm the integration of introduced DNA in the plant genome according to
standard
techniques (Sambrook and Russell, 2001, supra).
In Northern blot analysis, RNA is isolated from specific tissues of
transformant, fractionated in a formaldehyde agarose gel, blotted onto a nylon
filter
according to standard procedures that are routinely used in the art (Sambrook
and
Russell, 2001, supra). Expression of RNA encoded by a heterologous gene
operably
linked to the CTP-encoding sequence is then tested by hybridizing the filter
to a
radioactive probe derived from the heterologous gene, by methods known in the
art
(Sambrook and Russell, 2001, supra).
23
CA 02736244 2015-09-17
53645-25
Evaluation of CTP Activity
Assays to determine the efficiency by which the CTP sequences of the
invention target a protein of interest to a chloroplast are known. See, for
example,
Mishkind et al. (1985) J of Cell Biol 100:226-234.
A reporter gene such as-glucuronidase (GUS),
chloramphenicol acetyl transferase (CAT), or green fluorescent protein (GFP)
is
operably linked to the CTP sequence. This fusion is placed behind the control
of ,a
suitable promoter, ligated into a transformation vector, and transformed into
a plant or
plant cell. Following an adequate period of time for expression and
localization into
the chloroplast, the chloroplast fraction is extracted and reporter activity
assayed. The
ability of the isolated sequences to target and deliver the reporter protein
to the
chloroplast can be compared to other known CTP sequences. See de Castro Silva
Filho et al. (1996) Plant Mol. Biol. 30: 769-780. Protein import can also be
verified in
vitro through the addition of proteases to the isolated chloroplast fraction.
Proteins
which were successfully imported into the chloroplast are resistant to the
externally
added proteases whereas proteins that remain in the cytosol are susceptible to
digestion. Protein import can also be verified by the presence of functional
protein in
the chloroplast using standard molecular techniques for detection, or by
evaluating the
phenotype resulting from expression of a chloroplast targeted protein.
The following examples are offered by way of illustration and not by way of
limitation.
EXPERIMENTAL
Example 1. Chlantvdomonas AHAS CTP.
The Chlangdornonas AHAS CTP (SEQ NO:3) was identified from
comparison of the full-length Chlatnydomonas AHAS ("ChlamyAHAS") peptide
(GENBANK accession AF022816; SEQ ID NO:8) with several AHAS peptides from
plants, bacteria, yeast and fungi. This alignment shows that the ChlamyAHAS
CTP
shows very little sequence conservation with plant CTPs, whereas the mature
proteins
show conserved elements. Thus, by comparing the multiple AHAS proteins with
the
ChlamyAHAS protein, it was inferred that amino acids 1-99 of the
Chlamydotnonas
24
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
AHAS protein comprised the CTP. The predicted processing site for this CTP
upon
import into the Chlamydomonas chloroplast is at approximately amino acid 92 of
SEQ ID NO:8.
Example 2. Chlamydomonas RuBisCo Small Subunit (SSU) CTP.
The Chlamydomonas SSU CTP (SEQ ID NO:5) was identified from
comparison of the full¨length Chlamydomonas SSU ("ChlamySSU") peptide
(GENBANK accession CAA28160; SEQ ID NO:9) with several plant RuBisCo small
subunit peptides. This alignment shows that the ChlamySSU CTP shows very
little
sequence conservation with plant CTPs, whereas the mature proteins show
conserved
elements. Thus, by comparing the known processing sites of several plant
RuBisCo
proteins with the ChlamySSU protein, it was inferred that amino acids 1-45 of
the
Chlamydomonas SSU protein (SEQ ID NO:9) comprised the CTP.
The cleavage site for the Chlamydomonas RuBisCO small subunit precursor
("ChlamySSU") has been determined empirically to be between residues 44 and 45
of
SEQ ID NO:9 (Schmidt et al 1979, Journal of Cell Biology 83:615-662).
Example 3. Chlamydomonas EPSPS CTP.
The Chlamydomonas EPSPS CTP (SEQ ID NO:7) was identified from
comparison of the full-length Chlamydomonas EPSPS peptide (GENBANK accession
XP 001702942; SEQ ID NO:10) with several plant and bacterial EPSPSs. This
alignment showed that the ChlamyEPSPS CTP shows very little sequence
conservation with plant CTPs, whereas the mature proteins show conserved
elements.
Thus, by comparing several EPSPS proteins with the ChlamyEPSPS protein, it was
inferred that amino acids 1-75 of the Chlamydomonas EPSPS protein (SEQ ID
NO:10) comprised the CTP. The predicted processing site for this CTP upon
import
into the Chlamydomonas chloroplast is at approximately amino acid 61 of SEQ ID
NO:10.
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
Table 1. Chlamydomonas CTPs
Protein SEQ ID NO: Residues of Predicted
Precursor Protein Cleavage
Site
Used for CTP
ChlamyAHAS 8 1-99 92
ChlamySSU 9 1-45 Amino
Acid 44 or
Amino Acid 45
ChlamyEPSPS 10 1-75 61
Example 4. DNA constructs for using the Chlamydomonas CTPs for protein
targeting
A DNA element utilizing the Chlamydomonas CTP, including the
Chlamydomonas AHAS, Chlamydomonas SSU, or Chlamydomonas EPSPS CTPs to
generate multiple constructs for targeting of proteins to chloroplasts can
involve
inclusion of convenient restriction endonuclease recognition sites (for
example a Barn
HI restriction site) as well as small peptide linkers between the chloroplast
CTP and
the protein (for example a Gly-Ser-Gly tripeptide CTP; SEQ ID NO:18).
Furthermore,
such DNA elements can be designed and made synthetically, in a way that the
DNA
sequence is varied from the original DNA, but encodes the identical peptide.
Alternatively, one can design DNA constructs such that no restriction enzyme
sites are needed, and the CTP/protein fusion can be accomplished by total
synthesis of
the combined coding region, or by PCR based strategies, including "sewing PCR"
and
the like.
One can also design the CTP/protein fusion in a manner where some of either
protein is truncated. For example, one can remove one or more amino acids from
the
N-terminus of a bacterially expressed protein, and still achieve a functional
fusion to a
Chlamydomonas CTP.
A cassette containing a synthetically designed DNA sequence encoding the
Chlamydomonas AHAS CTP that incorporates a BamHI restriction site and a Gly-
Ser¨Gly linker was designed. These DNA constructs contain (from 5' to 3') (1)
a Psi' I
cloning site, (2) the bases ACC to provide "Kozak" context for efficient
translation,
(3) the portion of the gene encoding the amino terminal methionine through the
known transit peptide cleavage site of the ChlamyAHAS, and including a small
DNA
26
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
region encoding the amino acids C-terminal to the cleavage site, (4) DNA bases
encoding the residues Gly ¨ Ser ¨ Gly with an embedded BamH I cloning site,
and,
(5) the coding region of the gene of interest.
A cassette containing a synthetically designed DNA sequence encoding the
Chlamydomonas SSU CTP that incorporates a BamHI restriction site and a Gly-
Ser¨
Gly linker was designed. These DNA constructs contain (from 5' to 3') (1) a
Pst I
cloning site, (2) the bases ACC to provide "Kozak" context for efficient
translation,
(3) the portion of the gene encoding the amino terminal methionine through the
known transit peptide cleavage site of the ChlamySSU, and including a small
DNA
region encoding the amino acids C-terminal to the cleavage site, (4) DNA bases
encoding the residues Gly ¨ Ser ¨ Gly with an embedded BamH I cloning site,
and,
(5) the coding region of the gene of interest.
A cassette containing a synthetically designed DNA sequence encoding the
Chlamydomonas EPSPS CTP that incorporates a BamHI restriction site and a Gly-
Ser¨Gly linker was designed. These DNA constructs contain (from 5' to 3') (1)
a Psi' I
cloning site, (2) the bases ACC to provide "Kozak" context for efficient
translation,
(3) the portion of the gene encoding the amino terminal methionine through the
known transit peptide cleavage site of the ChlamyEPSPS, and including a small
DNA
region encoding the amino acids C-terminal to the cleavage site, (4) DNA bases
encoding the residues Gly ¨ Ser ¨ Gly with an embedded BamH I cloning site,
and,
(5) the coding region of the gene of interest.
Example 5. Fusion of a transit peptide from a non-plant species to a
heterologous
protein, and proper localization and cleavage in monocots: Chlamydomonas AHAS
CTP functions in monocots.
DNA constructs were designed such that the resulting protein encoded the
Chlamydomonas AHAS transit peptide ("ChlamyAHAS") at the N-terminus,
followed by a protein fusion to a gene conferring herbicide resistance upon
cells
(GRG-1; U.S. Patent No. 7,405,347). For the ChlamyAHAS precursor, the transit
peptide cleavage sites were inferred from alignments of the protein sequences
to ALS
proteins from bacteria, fungi and yeast.
These DNA constructs contain (from 5' to 3') a Psi' I cloning site, (2) the
bases
ACC to provide "Kozak" context for efficient translation, (3) the portion of
the gene
encoding the amino terminal methionine through the known transit peptide
cleavage
27
CA 02736244 2011-03-04
WO 2010/028331
PCT/US2009/056165
site of the ChlamyAHAS CTP and including a small DNA region encoding the amino
acids C-terminal to the cleavage site, (4) DNA bases encoding the residues Gly
¨ Ser
¨ Gly with an embedded BamH I cloning site, and, (5) the coding region of the
gene
of interest (in this case GRG-1).
These DNAs molecules were made synthetically (DNA 2.0 of Menlo Park,
CA). The DNA sequence of the region containing this construct is provided as
SEQ
ID NO:11, and the resulting amino acid sequence is provided as SEQ ID NO:12.
A control construct (pAG250) was made, which contains GRG-1 expressed
from the TrpPro5 promoter, wherein the GRG-1 protein does not have a
chloroplast
CTP.
This no CTP/GRG-1 construct was engineered into a vector for use in
Agrobacterium-mediated transformation of maize embryos, and transgenic maize
plants containing this construct were generated. To transformed plants were
analyzed
by PCR to confirm presence of the construct in the maize lines, and these To
plants
were then out-crossed to a non-transgenic line to generate hemizygous T1
progeny.
The resulting T1 transgenic plants produce large amounts of GRG-1 protein.
Nonetheless, plants transformed with pAG250 and expressing unlocalized GRG-1
are
not resistant to glyphosate.
The algal CTP ChlamyAHAS /GRG-1 construct was engineered into a vector
for use in Agrobacterium-mediated transformation of maize embryos, and
transgenic
maize plants containing this construct were generated.
To transformed plants were analyzed by PCR to confirm presence of the
construct in the maize lines, and these To plants were then out-crossed to a
non-
transgenic line to generate hemizygous T1 progeny. The resulting T1 transgenic
plants
are resistant to spray applications of glyphosate (as compared to non-
transgenic
controls).
Western blots of leaf tissue from transgenic maize plants show that these
plants express the GRG-1 protein. Furthermore, the size of the protein
identified by
Western blot is consistent with import of the protein into chloroplasts, and
processing
of the ChlamyAHAS/GRG-1 protein at or near the cleavage site.
Thus the ChlamyAHAS CTP is sufficient to target GRG-1 to the maize
chloroplast, and result in a phenotype (herbicide resistance) that is not
conferred by
GRG-1 in the absence of targeting to the chloroplast.
28
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
Example 6. Fusion of a transit peptide from a non-plant species to a
heterologous
protein, and proper localization and cleavage in monocots: Chlamydomonas SSU
CTP
functions in monocots
To test if an algal chloroplast CTP can function in monocots, transgenic
monocot plants were generated and expression and cleavage of an algal CTP was
assessed by Western blot analysis.
DNA constructs were designed such that the resulting protein encoded the
algal transit peptide at the N-terminus, fused to a protein conferring
herbicide
resistance upon cells (in this case the GRG-8 protein; U.S. Patent Publication
No.
20060150270)
These DNA constructs contain (from 5' to 3') (1) a Pst I cloning site, (2) the
bases ACC to provide "Kozak" context for efficient translation, (3) the
portion of the
gene encoding the amino terminal methionine through the known transit peptide
cleavage site of the ChlamySSU, and including a small DNA region encoding the
amino acids C-terminal to the cleavage site, (4) DNA bases encoding the
residues
Gly ¨ Ser ¨ Gly with an embedded BamH I cloning site, and, (5) the coding
region of
the gene of interest (in this case GRG-8).
The DNA sequence of the region containing this construct is provided as SEQ
ID NO:13, and the resulting amino acid sequence is provided as SEQ ID NO:14.
This CTP/GRG-8 construct (pAG1675) was engineered into a vector for use in
Agrobacterium-mediated transformation of maize embryos, and transgenic maize
plants generated and identified.
To plants transformed with pAG1675 were analyzed by PCR to confirm
presence of the construct in the maize lines, and these To plants were then
out-crossed
to a non-transgenic line to generate hemizygous T1 progeny. T1 transgenic
plants
exhibited resistance to spray applications of glyphosate compared to non-
transgenic
controls.
Example 7. Expression and processing of Chlamydomonas SSU chloroplast CTP
fused to GRG-8 protein in maize cells
Western blots of leaf tissue from transgenic maize plants were found to
express the CTP/GRG-8 protein. Total leaf protein was extracted from maize
leaves
(Pierce P-PER protein extract buffer) and separated on a 4-12% Bis-Tris gel.
GRG-8
protein was visualized using goat anti-GRG8 polyclonal antibodies. A non-
transgenic
29
CA 02736244 2015-09-17
53645-25
maize extract was compared alongside (lane 3). To evaluate CTP processing, a
HIS-
tagged GRG-8 protein standard was purified from an E. coli strain. The size of
the
protein identified by Western blot is consistent with import of the protein
into
chleroplasts, and processing of the CTP/GRG-8 protein within the ChlamySSU
CTP,
at or near the predicted cleavage site.
Example 8. Evaluation of glyphosate tolerance of maize plant expressing
Chlamvdomonas SSU-GRG8 protein
The glyphosate spray tolerance of a transgenic maize event expressing the
Chlamydomonas SSU-GRG8 protein was compared to several non-transgenic To
control plants. Individual plants were transferred to the greenhouse and grown
in flats
for 10 days. After 10 days, a glyphosate concentration that approximated a lx
field
TM
spray rate (7 mM supplemented with 0.1% Tween 20 as surfactant) was applied to
the
flats. The glyphosate was applied using a spray table to allow consistent
application
of the herbicide to individual plants. Plants were rated after 3 weeks to
determine if
the plants tolerated the glyphosate spray (mostly green leaf material: <50%
damage)
or did not tolerate the glyphosate spray (>75% damage, or plant death). The
transgenic plant showed tolerance to glyphosate, whereas each of the control
plants
failed to show tolerance.
Example 9. Fusion of a transit peptide from a non-plant species to a
heterologous
protein, and proper localization and cleavage in monocots: Chlamvdomonas EPSPS
CTP functions in monocots
DNA and amino acid sequences for the Chlamydonzonas EPSPS precursor
were obtained from public databases. The transit peptide cleavage site was
predicted
based on alignments of the protein sequences with EPSPS proteins from
bacteria,
fungi and yeast. A synthetic gene was constructed which encoded the CTP from
the
amino terminal methionine through the predicted cleavage site. This DNA was
ligated to create an in-frame fusion with the start codon of a synthetic GRG-
23(ace3)(R173K) gene (U.S. Patent Application Publication No. 20080127372).
This
CTP-GRG-23(ace3)(R173K) cassette was then ligated into a plant transformation
vector.
CA 02736244 2011-03-04
WO 2010/028331
PCT/US2009/056165
DNA constructs were designed such that the resulting protein encoded the
Chlamydomonas EPSPS ("ChlamyEPSPS") transit peptide at the N-terminus,
followed by fusion to a protein conferring herbicide resistance upon cells
(GRG-
23 (ace3)(R173K)).
These DNAs molecules were made synthetically (DNA 2.0 of Menlo Park,
CA). The DNA sequence of the region containing this construct is provided as
SEQ
ID NO:15, and the resulting amino acid sequence is provided as SEQ ID NO:16.
These DNA constructs contain (from 5' to 3'), (1) a Psi' I cloning site, (2)
the
bases ACC to provide "Kozak" context for efficient translation, (3) the
portion of the
gene encoding the amino terminal methionine through the known transit peptide
cleavage site of the ChlamyEPSPS and including a small DNA region encoding the
amino acids C-terminal to the cleavage site, (4) the coding region of the gene
of
interest (in this case GRG-23(ace3)(R173K).
This Chlamydomonas EPSPS CTP/ GRG-23(ace3)(R173K) construct was
engineered into a vector for use in Agrobacterium-mediated transformation of
maize
embryos, and transgenic events identified.
To transformed plants were analyzed by PCR to confirm presence of the
construct in the maize lines, and these To plants were then out-crossed to a
non-
transgenic line to generate hemizygous T1 progeny. The resulting T1 transgenic
plants
are resistant to spray applications of glyphosate (as compared to non-
transgenic
controls). Western blots of leaf tissue from transgenic maize plants were
found to
express the Chlamydomonas EPSPS CTP/GRG-23(ace3)(R173K) protein. The
protein detected in plant tissues is smaller than the full-length
Chlamydomonas
EPSPS ¨ GRG-23(ace3)(R173K) protein, and is similar in size to the native GRG-
23(ace3)(R173K) protein (Figure 2). The ability of the Chlamydomonas EPSPS
CTP/GRG-23(ace3)(R173K) protein to confer herbicide resistance and the size of
the
resulting mature GRG-23(ace3)(R173K) protein in herbicide resistant plants are
both
consistent with import of the protein into chloroplasts, and processing of the
Chlamydomonas EPSPS CTP/GRG-23(ace3)(R173K) protein at or near the cleavage
site.
31
CA 02736244 2011-03-04
WO 2010/028331
PCT/US2009/056165
Example 10. Molecular weight analysis of Chlamydomonas EPSPS ¨ GRG-
23(ace3)(R173K) protein expressed in maize.
From a Western blot of transgenic maize lines expressing Chlamydomonas
EPSPS ¨ GRG-23(ace3)(R173K) protein, the distance migration of protein
molecular
weight standards was graphed to generate a linear plot of Log Molecular Weight
vs.
Distance Migration (Figure 3). The linear regression equation of this plot was
used to
calculate the apparent molecular weight of the GRG23(ace3)(R173K) protein
standard (Figure 2, lane 8) and of the processed Chlamydomonas EPSPS ¨ GRG-
23(ace3)(R173K) protein detected in plant extract. By this method, the
apparent
molecular weight of the purified GRG23(ace3)(R173K) protein was determined to
be
45,347 grams/mole, and the apparent molecular weight of the processed
Chlamydomonas EPSPS ¨ GRG-23(ace3)(R173K) (lane 6, distance migration = 48.5
mm) was determined as 46,227 grams/mole. The estimated molecular weights of
the
processed proteins are consistent with processing of the Chlamydomonas CTP
several
amino acids upstream of its junction with GRG-23(ace3)(R173K) (the molecular
weight of GRG23(ace3)(R173K) is estimated to be 45,570 grams/mole). No protein
of a size consistent with unprocessed Chlamydomonas EPSPS ¨ GRG-
23(ace3)(R173K) protein (MW = 52,012 grams/mole) is detected by Western blot.
Therefore, the Chlamydomonas EPSPS CTP is processed in maize at a discrete
recognition site within the Chlamydomonas CTP. Purification and N-terminal
amino
acid analysis of this protein by methods known in the art would allow
unambiguous
determination of the exact cleavage site within the Chlamydomonas CTP.
Example 11. Evaluation of algal CTP sequences in dicots
To assess the ability of algal chloroplast CTPs to function in dicot cells,
the
Chlamydomonas AHAS Chloroplast CTP (SEQ ID NO:3) was positioned in frame 5'
of TagGFP gene (Evrogen, Moscow, Russia). A control vector contained the
TagGFP
gene without a chloroplast transit peptide. The ChlamyAHAS CTP construct
(pAX3517) and control construct (pAX3521) were organized to initiate
transcription
from the Arabidopsis UBQ3 promoter (Norris et. al, 1993, Plant Molecular
Biology
21:895-906). Constructs utilized either 35S or PinII transcriptional
terminators.
Approximately twelve micrograms of each purified plasmid was used in
polyethylene glycol-mediated tobacco protoplast transformation experiments.
After
32
CA 02736244 2011-03-04
WO 2010/028331 PCT/US2009/056165
transformation, the protoplasts were incubated in a growth chamber at 25 C for
23
hours. Expression and localization of TagGFP protein following transient
expression
was monitored under an inverted fluorescent microscope.
The construct expressing the TagGFP without a chloroplast CTP was detected
only in the cytoplasm of protoplasts. However, the Chlamydomonas AHAS CTP
construct correctly delivered TagGFP into the chloroplast resulting in
accumulation of
florescence in the chloroplast of these protoplasts (Figure 1).
Example 12. Evaluation of an algal CTP sequence in soybean cells
To assess the ability of algal chloroplast CTPs to function in soybean cells,
the
ChlamyAHAS CTP construct (pAX3517), the ChlamyEPSPS construct (pAX4562),
and a control construct (pAX3521) containing the TagGFP gene without a
chloroplast
transit peptide were used in polyethylene glycol-mediated transformation of
soybean
protoplasts. Expression and localization of TagGFP protein following transient
expression was monitored under an inverted fluorescent microscope.
For the control construct lacking a chloroplast CTP, TagGFP fluorescence was
observed only in the cytoplasm. Similarly, no expression in the chloroplasts
was
observed from two independent constructs expressing TagGFP with the
ChlamyEPSPS chloroplast CTP. However, TagGFP was detected in the chloroplast
of protoplasts that had been transformed with the ChlamyAHAS chloroplast CTP
construct. Thus, this CTP functions in soybean and well as tobacco cells.
Table 2. Localization of algal chloroplast CTP-linked proteins in dicot cells.
Construct CTP Gene Localization of Localization of
TagGFP in tobacco TagGFP in
Protoplasts soybean
Protoplasts
pAX3517 ChlamyAHAS TagGFP Chloroplast Chloroplast
pAX4562 ChlamyEPSPS TagGFP not tested Non-
Chloroplast
pAX3521 None TagGFP Non-Chloroplast Non-
Chloroplast
33
CA 02736244 2015-09-17
53645-25
Table 3. Summary of function of Chlamydomonas CTPs in Plant Cells
CTP Function in Function in
Monocot cells Dicot Cells
ChlamySSU ++ not tested
ChlamyEPSPS +++
ChlamyAHAS +++ +++
All publications and patent applications mentioned in the specification are
indicative of the level of skill of those skilled in the art to which this
invention
pertains.
Although the foregoing invention has been described in some detail by way of
illustration and example for purposes of clarity of understanding, it will be
obvious
that certain changes and modifications may be practiced within the scope of
the
appended claims.
SEQUENCE LISTING IN ELECTRONIC FORM
In accordance with Section 111(1) of the Patent Rules, this description
contains a sequence listing in electronic form in ASCII text format
(file: 53645-25 Seq 03-FEB-11 vl.txt).
A copy of the sequence listing in electronic form is available from the
Canadian Intellectual Property Office.
The sequences in the sequence listing in electronic form are reproduced
in the following table.
SEQUENCE TABLE
<110> Philip E. Hammer
Vadim Beilinson
Todd K. Hinson
<120> COMPOSITIONS AND METHODS FOR EXPRESSION
OF A HETEROLOGOUS NUCLEOTIDE SEQUENCE IN PLANTS
<130> 045600/377480
<140> PCT/US2009/056165
<141> 2009-09-08
34
CA 02736244 2011-03-04
<150> 61/095,134
<151> 2008-09-08
<160> 18
<170> FastSEQ for Windows Version 4.0
<210> 1
<211> 297
<212> DNA
<213> Chlamydomonas reinhardtii
<400> 1
atgaaggccc tgcgaagtgg aaccgctgtg gcgcggggcc aagcgggctg tgtttctccc 60
gctccgcgcc ctgtgcctat gtcgtctcag gcgatgattc cgagcaccag ctccccagca 120
gctcgtgcac ccgcccggtc cggtcgccgc gccctcgctg tgtcggccaa gctggctgat 180
gggtctcgtc gcatgcagtc cgaggaggtg cgccgcgcca aggaggtggc ccaggctgcg 240
ctggccaagg acagccctgc cgactgggtg gaccgctacg gctcggagcc gcgcaag 297
<210> 2
<211> 297
<212> DNA
<213> Chlamydomonas reinhardtii
<400> 2
atgaaggccc tgcgaagtgg aaccgctgtg gcgcggggcc aagcgggctg tgtttctccc 60
gctccgcgcc ctgtgcctat gtcgtctcag gcgatgattc cgagcaccag ctccccagca 120
gctcgtgcac ccgcccggtc cggtcgccgc gccctcgctg tgtcggccaa gctggctgat 180
gggtcacgtc gcatgcagtc cgaggaggtg cgccgcgcca aggaggtggc ccaggctgcg 240
ctggctaagg acagccctgc cgactgggta gaccgctacg gctcggagcc gcgcaag 297
<210> 3
<211> 99
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 3
Met Lys Ala Leu Arg Ser Gly Thr Ala Val Ala Arg Gly Gin Ala Gly
1 5 10 15
Cys Val Ser Pro Ala Pro Arg Pro Val Pro Met Ser Ser Gin Ala Met
20 25 30
Ile Pro Ser Thr Ser Ser Pro Ala Ala Arg Ala Pro Ala Arg Ser Gly
35 40 45
Arg Arg Ala Leu Ala Val Ser Ala Lys Leu Ala Asp Gly Ser Arg Arg
50 55 60
Met Gin Ser Glu Glu Val Arg Arg Ala Lys Glu Val Ala Gln Ala Ala
65 70 75 80
Leu Ala Lys Asp Ser Pro Ala Asp Trp Val Asp Arg Tyr Gly Ser Glu
85 90 95
Pro Arg Lys
<210> 4
<211> 135
<212> DNA
<213> Chlamydomonas reinhardtii
<400> 4
atggccgccg tcattgccaa gtcctccgtc tccgcggccg tggcccgccc ggcccgctcc 60
agcgtgcgcc ccatggccgc gctgaagccc gccgtcaagg ccgcccccgt ggctgccccg 120
gctcaggcta accag 135
34a
CA 02736244 2011-03-04
<210> 5
<211> 45
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 5
Met Ala Ala Val Ile Ala Lys Ser Ser Val Ser Ala Ala Val Ala Arg
1 5 10 15
Pro Ala Arg Ser Ser Val Arg Pro Met Ala Ala Leu Lys Pro Ala Val
20 25 30
Lys Ala Ala Pro Val Ala Ala Pro Ala Gln Ala Asn Gln
35 40 45
<210> 6
<211> 225
<212> DNA
<213> Chlamydomonas reinhardtii
<400> 6
atgcagctgc tcaaccagcg gcaggcgctg cggctgggaa gaagctccgc cagcaagaac 60
cagcaggtgg cgccgctggc atcaaggccg gcaagcagcc tctccgtctc cgcctcctcc 120
gtggcgccgg cgccggcctg ctcggcgccg gccggcgccg gccgccgcgc cgtggtggtg 180
cgcgcctccg ccaccaagga gaaggtggag gagctcacca tccag 225
<210> 7
<211> 75
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 7
Met Gln Leu Leu Asn Gln Arg Gln Ala Leu Arg Leu Gly Arg Ser Ser
1 5 10 15
Ala Ser Lys Asn Gln Gln Val Ala Pro Leu Ala Ser Arg Pro Ala Ser
20 25 30
Ser Leu Ser Val Ser Ala Ser Ser Val Ala Pro Ala Pro Ala Cys Ser
35 40 45
Ala Pro Ala Gly Ala Gly Arg Arg Ala Val Val Val Arg Ala Ser Ala
50 55 60
Thr Lys Glu Lys Val Glu Glu Leu Thr Ile Gln
65 70 75
<210> 8
<211> 683
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 8
Met Lys Ala Leu Arg Ser Gly Thr Ala Val Ala Arg Gly Gln Ala Gly
1 5 10 15
Cys Val Ser Pro Ala Pro Arg Pro Val Pro Met Ser Ser Gln Ala Met
20 25 30
Ile Pro Ser Thr Ser Ser Pro Ala Ala Arg Ala Pro Ala Arg Ser Gly
35 40 45
Arg Arg Ala Leu Ala Val Ser Ala Lys Leu Ala Asp Gly Ser Arg Arg
50 55 60
Met Gln Ser Glu Glu Val Arg Arg Ala Lys Glu Val Ala Gln Ala Ala
65 70 75 80
Leu Ala Lys Asp Ser Pro Ala Asp Trp Val Asp Arg Tyr Gly Ser Glu
85 90 95
Pro Arg Lys Gly Ala Asp Ile Leu Val Gln Ala Leu Glu Arg Glu Gly
100 105 110
34b
CA 02736244 2011-03-04
Val Asp Ser Val Phe Ala Tyr Pro Gly Gly Ala Ser Met Glu Ile His
115 120 125
Gln Ala Leu Thr Arg Ser Asp Arg' lie Thr Asn Val Leu Cys Arg His
130 135 140
Glu Gln Gly Glu Ile Phe Ala Ala Glu Gly Tyr Ala Lys Ala Ala Gly
145 150 155 160
Arg Val Gly Val Cys Ile Ala Thr Ser Gly Pro Gly Ala Thr Asn Leu
165 170 175
Val Thr Gly Leu Ala Asp Ala Met Met Asp Ser Ile Pro Leu Val Ala
180 185 190
Ile Thr Gly Gln Val Pro Arg Arg Met Ile Gly Thr Asp Ala Phe Gln
195 200 205
Glu Thr Pro Ile Val Glu Val Thr Arg Ala Ile Thr Lys His Asn Tyr
210 215 220
Leu Val Leu Asp Ile Lys Asp Leu Pro Arg Val Ile Lys Glu Ala Phe
225 230 235 240
Tyr Leu Ala Arg Thr Gly Arg Pro Gly Pro Val Leu Val Asp Val Pro
245 250 255
Lys Asp Ile Gln Gln Gln Leu Ala Val Pro Asp Trp Glu Ala Pro Met
260 265 270
Ser Ile Thr Gly Tyr Ile Ser Arg Leu Pro Pro Pro Val Glu Glu Ser
275 280 285
Gln Val Leu Pro Val Leu Arg Ala Leu Gln Gly Ala Ala Lys Pro Val
290 295 300
Ile Tyr Tyr Gly Gly Gly Cys Leu Asp Ala Gln Ala Glu Leu Arg Glu
305 310 315 320
Phe Ala Ala Arg Thr Gly Ile Pro Leu Ala Ser Thr Phe Met Gly Leu
325 330 335
Gly Val Val Pro Ser Thr Asp Pro Asn His Leu Gln Met Leu Gly Met
340 345 350
His Gly Thr Val Phe Ala Asn Tyr Ala Val Asp Gln Ala Asp Leu Leu
355 360 365
Val Ala Leu Gly Val Arg Phe Asp Asp Arg Val Thr Gly Lys Leu Asp
370 375 380
Ala Phe Ala Ala Arg Ala Arg Ile Val His Ile Asp Ile Asp Ala Ala
385 390 395 400
Glu Ile Ser Lys Asn Lys Thr Ala His Val Pro Val Cys Gly Asp Val
405 410 415
Lys Gln Ala Leu Ser His Leu Asn Arg Leu Leu Ala Ala Glu Pro Leu
420 425 430
Pro Ala Asp Lys Trp Ala Gly Trp Arg Ala Glu Leu Ala Ala Lys Arg
435 440 445
Ala Glu Phe Pro Met Arg Tyr Pro Gln Arg Asp Asp Ala Ile Val Pro
450 455 460
Gln His Ala Ile Gln Val Leu Gly Glu Glu Thr Gln Gly Glu Ala Ile
465 470 475 480
Ile Thr Thr Gly Val Gly Gln His Gln Met Trp Ala Ala Gln Trp Tyr
485 490 495
Pro Tyr Lys Glu Thr Arg Arg Trp Ile Ser Ser Gly Gly Leu Gly Ser
500 505 510
Met Gly Phe Gly Leu Pro Ala Ala Leu Gly Ala Ala Val Ala Phe Asp
515 520 525
Gly Lys Asn Gly Arg Pro Lys Lys Thr Val Val Asp Ile Asp Gly Asp
530 535 540
Gly Ser Phe Leu Met Asn Val Gln Glu Leu Ala Thr Ile Phe Ile Glu
545 550 555 560
Lys Leu Asp Val Lys Val Met Leu Leu Asn Asn Gln His Leu Gly Met
565 570 575
Val Val Gln Trp Glu Asp Arg Phe Tyr Lys Ala Asn Arg Ala His Thr
580 585 590
Tyr Leu Gly Lys Arg Glu Ser Glu Trp His Ala Thr Gln Asp Glu Glu
595 600 605
Asp Ile Tyr Pro Asn Phe Val Asn Met Ala Gln Ala Phe Gly Val Pro
610 615 620
34c
CA 02736244 2011-03-04
Ser Arg Arg Val Ile Val Lys Glu Gln Leu Arg Gly Ala Ile Arg Thr
625 630 635 640
Met Leu Asp Thr Pro Gly Pro Tyr Leu Leu Glu Val Met Val Pro His
645 650 655
Ile Glu His Val Leu Pro Met Ile Pro Gly Gly Ala Ser Phe Lys Asp
660 665 670
Ile Ile Thr Glu Gly Asp Gly Thr Val Lys Tyr
675 680
<210> 9
<211> 185
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 9
Met Ala Ala Val Ile Ala Lys Ser Ser Val Ser Ala Ala Val Ala Arg
1 5 10 15
Pro Ala Arg Ser Ser Val Arg Pro Met Ala Ala Leu Lys Pro Ala Val
20 25 30
Lys Ala Ala Pro Val Ala Ala Pro Ala Gln Ala Asn Gln Met Met Val
35 40 45
Trp Thr Pro Val Asn Asn Lys Met Phe Glu Thr Phe Ser Tyr Leu Pro
50 55 60
Pro Leu Ser Asp Glu Gln Ile Ala Ala Gln Val Asp Tyr Ile Val Ala
65 70 75 80
Asn Gly Trp Ile Pro Cys Leu Glu Phe Ala Glu Ser Asp Lys Ala Tyr
85 90 95
Val Ser Asn Glu Ser Ala Ile Arg Phe Gly Ser Val Ser Cys Leu Tyr
100 105 110
Tyr Asp Asn Arg Tyr Trp Thr Met Trp Lys Leu Pro Met Phe Gly Cys
115 120 125
Arg Asp Pro Met Gln Val Leu Arg Glu Ile Val Ala Cys Thr Lys Ala
130 135 140
Phe Pro Asp Ala Tyr Val Arg Leu Val Ala Phe Asp Asn Gln Lys Gln
145 150 155 160
Val Gln Ile Met Gly Phe Leu Val Gln Arg Pro Lys Ser Ala Arg Asp
165 170 175
Trp Gln Pro Ala Asn Lys Arg Ser Val
180 185
<210> 10
<211> 512
<212> PRT
<213> Chlamydomonas reinhardtii
<400> 10
Met Gln Leu Leu Asn Gln Arg Gln Ala Leu Arg Leu Gly Arg Ser Ser
1 5 10 15
Ala Ser Lys Asn Gln Gln Val Ala Pro Leu Ala Ser Arg Pro Ala Ser
20 25 30
Ser Leu Ser Val Ser Ala Ser Ser Val Ala Pro Ala Pro Ala Cys Ser
35 40 45
Ala Pro Ala Gly Ala Gly Arg Arg Ala Val Val Val Arg Ala Ser Ala
50 55 60
Thr Lys Glu Lys Val Glu Glu Leu Thr Ile Gln Pro Val Lys Lys Ile
65 70 75 80
Ala Gly Thr Val Lys Leu Pro Gly Ser Lys Ser Leu Ser Asn Arg Ile
85 90 95
Leu Leu Leu Ala Ala Leu Ser Glu Gly Thr Thr Leu Val Lys Asn Leu
100 105 110
Leu Asp Ser Asp Asp Ile Arg Tyr Met Val Gly Ala Leu Lys Ala Leu
115 120 125
34d
CA 02736244 2011-03-04
Asn Val Lys Leu Glu Glu Asn Trp Glu Ala Gly Glu Met Val Val His
130 135 140
Gly Cys Gly Gly Arg Phe Asp Ser Ala Gly Ala Glu Leu Phe Leu Gly
145 150 155 160
Asn Ala Gly Thr Ala Met Arg Pro Leu Thr Ala Ala Val Val Ala Ala
165 170 175
Gly Arg Gly Lys Phe Val Leu Asp Gly Val Ala Arg Met Arg Glu Arg
180 185 190
Pro Ile Glu Asp Leu Val Asp Gly Leu Val Gln Leu Gly Val Asp Ala
195 200 205
Lys Cys Thr Met Gly Thr Gly Cys Pro Pro Val Glu Val Asn Ser Lys
210 215 220
Gly Leu Pro Thr Gly Lys Val Tyr Leu Ser Gly Lys Val Ser Ser Gln
225 230 235 240
Tyr Leu Thr Ala Leu Leu Met Ala Ala Pro Leu Ala Val Pro Gly Gly
245 250 255
Ala Gly Gly Asp Ala Ile Glu Ile Ile Ile Lys Asp Glu Leu Val Ser
260 265 270
Gln Pro Tyr Val Asp Met Thr Val Lys Leu Met Glu Arg Phe Gly Val
275 280 285
Val Val Glu Arg Leu Asn Gly Leu Gln His Leu Arg Ile Pro Ala Gly
290 295 300
Gln Thr Tyr Lys Thr Pro Gly Glu Ala Tyr Val Glu Gly Asp Ala Ser
305 310 315 320
Ser Ala Ser Tyr Phe Leu Ala Gly Ala Thr Ile Thr Gly Gly Thr Val
325 330 335
Thr Val Glu Gly Cys Gly Ser Asp Ser Leu Gln Gly Asp Val Arg Phe
340 345 350
Ala Glu Val Met Gly Leu Leu Gly Ala Lys Val Glu Trp Ser Pro Tyr
355 360 365
Ser Ile Thr Ile Thr Gly Pro Ser Ala Phe Gly Lys Pro Ile Thr Gly
370 375 380
Ile Asp His Asp Cys Asn Asp Ile Pro Asp Ala Ala Met Thr Leu Ala
385 390 395 400
Val Ala Ala Leu Phe Ala Asp Arg Pro Thr Ala Ile Arg Asn Val Tyr
405 410 415
Asn Trp Arg Val Lys Glu Thr Glu Arg Met Val Ala Ile Val Thr Glu
420 425 430
Leu Arg Lys Leu Gly Ala Glu Val Glu Glu Gly Arg Asp Tyr Cys Ile
435 440 445
Val Thr Pro Pro Pro Gly Gly Val Lys Gly Val Lys Ala Asn Val Gly
450 455 460
Ile Asp Thr Tyr Asp Asp His Arg Met Ala Met Ala Phe Ser Leu Val
465 470 475 480
Ala Ala Ala Gly Val Pro Val Val Ile Arg Asp Pro Gly Cys Thr Arg
485 490 495
Lys Thr Phe Pro Thr Tyr Phe Lys Val Phe Glu Ser Val Ala Gln His
500 505 510
<210> 11
<211> 1602
<212> DNA
<213> Artificial Sequence
<220>
<223> synthetic Ch1amyAHAS/GRG1 construct
<400> 11
atgaaggccc tgcgaagtgg aaccgctgtg gcgcggggcc aagcgggctg tgtttctccc 60
gctccgcgcc ctgtgcctat gtcgtctcag gcgatgattc cgagcaccag ctccccagca 120
gctcgtgcac ccgcccggtc cggtcgccgc gccctcgctg tgtcggccaa gctggctgat 180
gggtctcgtc gcatgcagtc cgaggaggtg cgccgcgcca aggaggtggc ccaggctgcg 240
ctggccaagg acagccctgc cgactgggtg gaccgctacg gctcggagcc gcgcaaggga 300
34e
CA 02736244 2011-03-04
tccggcatga aggtgacaat ccagcctggc gatctcacag gcatcattca gagcccagcg 360
tcaaagtctt caatgcagag agcgtgcgcg gcggccctgg tggcgaaggg gatctcagaa 420
atcatcaacc ctgggcatag caacgatgat aaggccgcga gagatatcgt gagccgtctt 480
ggggccagac ttgaagatca gccagatggc agcctccaga tcacttcaga aggcgttaag 540
ccagtggcgc ctttcatcga ttgcggggaa tcagggctgt ctatccgcat gttcacacca 600
atcgtggcgc tctcaaagga agaagtgaca atcaaggggt cagggtcact cgttactcgc 660
cctatggatt tcttcgatga aatcctgcca catctgggcg tgaaggtgaa gtcaaatcag 720
gggaagctcc ctctggttat ccaggggcca cttaagccag cggatgttac agttgatggg 780
tctctctcat ctcagttcct gacaggcctc ctgcttgcct acgccgcggc ggatgccagc 840
gatgttgcca tcaaggtgac taacctgaag tcacgtcctt acatcgatct tactcttgat 900
gttatgaagc gtttcggcct caagactcct gaaaaccgca actacgaaga gttctacttc 960
aaggccggga acgtgtacga cgaaacaaag atgcagcgtt acactgttga aggggattgg 1020
tcagggggcg cgttcctgct cgttgcgggg gccatcgccg ggccaatcac tgttcgtggc 1080
cttgatatcg cgtcaactca ggcggataag gcgatcgttc aggcgctcat gagcgccaac 1140
gccgggatcg cgatcgatgc caaggaaatc aagctgcatc ctgccgatct gaacgccttc 1200
gagttcgatg ccactgattg ccctgatctc ttcccaccac tcgtggccct cgcctcatac 1260
tgcaaggggg aaacaaagat caagggcgtg agccgccttg cgcataagga atctgataga 1320
gggctgactc ttcaggatga gttcgggaag atgggcgttg aaatccatct tgaaggggat 1380
ctcatgcgtg tgatcggcgg gaagggggtg aagggcgccg aagttagctc acgtcatgat 1440
catcgcatcg ccatggcgtg cgccgtggcg gcgctcaagg ccgttgggga aacaacaatc 1500
gaacatgccg aagcggttaa caagtcttac cctgatttct actcagattt gaagcagctc 1560
gggggcgtgg tgtctctgaa ccatcagttc aacttctctt ag 1602
<210> 12
<211> 533
<212> PRT
<213> Artificial Sequence
<220>
<223> synthetic Ch1amyAHAS/GRG1 construct
<400> 12
Met Lys Ala Leu Arg Ser Gly Thr Ala Val Ala Arg Gly Gln Ala Gly
1 5 10 15
Cys Val Ser Pro Ala Pro Arg Pro Val Pro Met Ser Ser Gln Ala Met
20 25 30
Ile Pro Ser Thr Ser Ser Pro Ala Ala Arg Ala Pro Ala Arg Ser Gly
35 40 45
Arg Arg Ala Leu Ala Val Ser Ala Lys Leu Ala Asp Gly Ser Arg Arg
50 55 60
Met Gln Ser Glu Glu Val Arg Arg Ala Lys Glu Val Ala Gln Ala Ala
65 70 75 80
Leu Ala Lys Asp Ser Pro Ala Asp Trp Val Asp Arg Tyr Gly Ser Glu
85 90 95
Pro Arg Lys Gly Ser Gly Met Lys Val Thr Ile Gln Pro Gly Asp Leu
100 105 110
Thr Gly Ile Ile Gln Ser Pro Ala Ser Lys Ser Ser Met Gln Arg Ala
115 120 125
Cys Ala Ala Ala Leu Val Ala Lys Gly Ile Ser Glu Ile Ile Asn Pro
130 135 140
Gly His Ser Asn Asp Asp Lys Ala Ala Arg Asp Ile Val Ser Arg Leu
145 150 155 160
Gly Ala Arg Leu Glu Asp Gln Pro Asp Gly Ser Leu Gln Ile Thr Ser
165 170 175
Glu Gly Val Lys Pro Val Ala Pro Phe Ile Asp Cys Gly Glu Ser Gly
180 185 190
Leu Ser Ile Arg Met Phe Thr Pro Ile Val Ala Leu Ser Lys Glu Glu
195 200 205
Val Thr Ile Lys Gly Ser Gly Ser Leu Val Thr Arg Pro Met Asp Phe
210 215 220
Phe Asp Glu Ile Leu Pro His Leu Gly Val Lys Val Lys Ser Asn Gln
225 230 235 240
34f
CA 02736244 2011-03-04
Gly Lys Leu Pro Leu Val Ile Gin Gly Pro Leu Lys Pro Ala Asp Val
245 250 255
Thr Val Asp Gly Ser Leu Ser Ser Gin Phe Leu Thr Gly Leu Leu Leu
260 265 270
Ala Tyr Ala Ala Ala Asp Ala Ser Asp Val Ala Ile Lys Val Thr Asn
275 280 285
Leu Lys Ser Arg Pro Tyr Ile Asp Leu Thr Leu Asp Val Met Lys Arg
290 295 300
Phe Gly Leu Lys Thr Pro Glu Asn Arg Asn Tyr Glu Glu Phe Tyr Phe
305 310 315 320
Lys Ala Gly Asn Val Tyr Asp Glu Thr Lys Met Gin Arg Tyr Thr Val
325 330 335
Glu Gly Asp Trp Ser Gly Gly Ala Phe Leu Leu Val Ala Gly Ala Ile
340 345 350
Ala Gly Pro Ile Thr Val Arg Gly Leu Asp Ile Ala Ser Thr Gin Ala
355 360 365
Asp Lys Ala Ile Val Gin Ala Leu Met Ser Ala Asn Ala Gly Ile Ala
370 375 380
Ile Asp Ala Lys Glu Ile Lys Leu His Pro Ala Asp Leu Asn Ala Phe
385 390 395 400
Glu Phe Asp Ala Thr Asp Cys Pro Asp Leu Phe Pro Pro Leu Val Ala
405 410 415
Leu Ala Ser Tyr Cys Lys Gly Glu Thr Lys Ile Lys Gly Val Ser Arg
420 425 430
Leu Ala His Lys Glu Ser Asp Arg Gly Leu Thr Leu Gin Asp Glu Phe
435 440 445
Gly Lys Met Gly Val Glu Ile His Leu Glu Gly Asp Leu Met Arg Val
450 455 460
Ile Gly Gly Lys Gly Val Lys Gly Ala Glu Val Ser Ser Arg His Asp
465 470 475 480
His Arg Ile Ala Met Ala Cys Ala Val Ala Ala Leu Lys Ala Val Gly
485 490 495
Glu Thr Thr Ile Glu His Ala Glu Ala Val Asn Lys Ser Tyr Pro Asp
500 505 510
Phe Tyr Ser Asp Leu Lys Gin Leu Gly Gly Val Val Ser Leu Asn His
515 520 525
Gin Phe Asn Phe Ser
530
<210> 13
<211> 1413
<212> DNA
<213> Artificial Sequence
<220>
<223> synthetic ChlamyAHAS/GRG8 construct
<400> 13
ctgcagacca tggccgccgt cattgccaag tcctccgtct ccgcggccgt ggcccgcccg 60
gcccgctcca gcgtgcgccc catggccgcg ctgaagcccg ccgtcaaggc cgcccccgtg 120
gctgccccgg ctcaggctaa ccagggatcc ggcatgatga tgggtagagc caaactcacg 180
attatcccgc cgggcaagcc tttgaccgga cgcgccatgc cgccgggatc gaagtcgatc 240
accaaccgcg cattgctgct cgccggcctc gccaagggca cgagccggct aaccggtgcg 300
ctgaagagcg acgatacccg ctatatggcc gaagcgctgc gtgcgatggg tgtaacgatc 360
gacgagcccg acgacaccac gttcatcgtc aaaggcagcg gcaagctgca gccgccggca 420
gccccgcttt tcctcggcaa tgccggcacg gcaacgcgct tcctgacggc ggccgcggca 480
ctggtggacg gcaaggtcat cgtcgacggc gatgcccata tgcgcaagcg gccgatcgga 540
ccgctagtcg acgcgttgcg ctcgctcggc atcgatgcct cggctgaaac cggctgcccg 600
ccagtcacga tcaacggcac cggccgcttc gaggcaagcc gcgtgcagat cgatggcggc 660
ctgtccagcc agtatgtctc ggcgctcctg atgatggccg ccggcggcga tcgcgctgtc 720
gatgtcgagc ttctcggcga acatatcggc gctctcggct atatcgacct gaccgttgcc 780
gccatgcgcg ctttcggcgc gaaggttgag cgtgtgagcc cggtcgcctg gcgcgtcgag 840
cccaccggct atcatgcggc cgacttcgtg atcgagccgg atgcctctgc tgcgacctat 900
34g
CA 02736244 2011-03-04
ctctgggccg ccgaagttct gagcggcggc aagatcgatc tcggcacgcc ggcggaacag 960
ttctcgcaac cggatgcgaa agcctatgat ctgatttcga aattcccgca tctgcctgct 1020
gtcatcgacg gctcgcagat gcaggacgcc atcccgacgc tcgccgttct cgccgctttc 1080
aacgaaatgc ctgtgcgctt cgtcggtatc gaaaacctgc gcgtcaagga atgcgatcgt 1140
atccgcgcgc tctcgagcgg cctatcccgc atcgttccga acctcggcac ggaagagggc 1200
gacgatctca tcatcgcctc cgatccgagc cttgccggca aaatcctgac cgcagagatc 1260
gatagctttg ccgatcaccg catcgccatg agctttgcgc tggccggcct gaagatcggc 1320
ggcattacca ttctcgaccc cgactgcgtc gccaagacat tcccgtccta ctggaatgtg 1380
ctgtcttcgc tgggggtcgc ctacgaagac tga 1413
<210> 14
<211> 467
<212> PRT
<213> Artificial Sequence
<220>
<223> synthetic ChlamyAHAS/GRG8 construct
<400> 14
Met Ala Ala Val Ile Ala Lys Ser Ser Val Ser Ala Ala Val Ala Arg
1 5 10 15
Pro Ala Arg Ser Ser Val Arg Pro Met Ala Ala Leu Lys Pro Ala Val
20 25 30
Lys Ala Ala Pro Val Ala Ala Pro Ala Gln Ala Asn Gln Gly Ser Gly
35 40 45
Met Met Met Gly Arg Ala Lys Leu Thr Ile Ile Pro Pro Gly Lys Pro
50 55 60
Leu Thr Gly Arg Ala Met Pro Pro Gly Ser Lys Ser Ile Thr Asn Arg
65 70 75 80
Ala Leu Leu Leu Ala Gly Leu Ala Lys Gly Thr Ser Arg Leu Thr Gly
85 90 95
Ala Leu Lys Ser Asp Asp Thr Arg Tyr Met Ala Glu Ala Leu Arg Ala
100 105 110
Met Gly Val Thr Ile Asp Glu Pro Asp Asp Thr Thr Phe Ile Val Lys
115 120 125
Gly Ser Gly Lys Leu Gln Pro Pro Ala Ala Pro Leu Phe Leu Gly Asn
130 135 140
Ala Gly Thr Ala Thr Arg Phe Leu Thr Ala Ala Ala Ala Leu Val Asp
145 150 155 160
Gly Lys Val Ile Val Asp Gly Asp Ala His Met Arg Lys Arg Pro Ile
165 170 175
Gly Pro Leu Val Asp Ala Leu Arg Ser Leu Gly Ile Asp Ala Ser Ala
180 185 190
Glu Thr Gly Cys Pro Pro Val Thr Ile Asn Gly Thr Gly Arg Phe Glu
195 200 205
Ala Ser Arg Val Gln Ile Asp Gly Gly Leu Ser Ser Gln Tyr Val Ser
210 215 220
Ala Leu Leu Met Met Ala Ala Gly Gly Asp Arg Ala Val Asp Val Glu
225 230 235 240
Leu Leu Gly Glu His Ile Gly Ala Leu Gly Tyr Ile Asp Leu Thr Val
245 250 255
Ala Ala Met Arg Ala Phe Gly Ala Lys Val Glu Arg Val Ser Pro Val
260 265 270
Ala Trp Arg Val Glu Pro Thr Gly Tyr His Ala Ala Asp Phe Val Ile
275 280 285
Glu Pro Asp Ala Ser Ala Ala Thr Tyr Leu Trp Ala Ala Glu Val Leu
290 295 300
Ser Gly Gly Lys Ile Asp Leu Gly Thr Pro Ala Glu Gln Phe Ser Gln
305 310 315 320
Pro Asp Ala Lys Ala Tyr Asp Leu Ile Ser Lys Phe Pro His Leu Pro
325 330 335
Ala Val Ile Asp Gly Ser Gln Met Gln Asp Ala Ile Pro Thr Leu Ala
340 345 350
34h
CA 02736244 2011-03-04
Val Leu Ala Ala Phe Asn Glu Met Pro Val Arg Phe Val Gly Ile Glu
355 360 365
Asn Leu Arg Val Lys Glu Cys Asp Arg Ile Arg Ala Leu Ser Ser Gly
370 375 380
Leu Ser Arg Ile Val Pro Asn Leu Gly Thr Glu Glu Gly Asp Asp Leu
385 390 395 400
Ile Ile Ala Ser Asp Pro Ser Leu Ala Gly Lys Ile Leu Thr Ala Glu
405 410 415
Ile Asp Ser Phe Ala Asp His Arg Ile Ala Met Ser Phe Ala Leu Ala
420 425 430
Gly Leu Lys Ile Gly Gly Ile Thr Ile Leu Asp Pro Asp Cys Val Ala
435 440 445
Lys Thr Phe Pro Ser Tyr Trp Asn Val Leu Ser Ser Leu Gly Val Ala
450 455 460
Tyr Glu Asp
465
<210> 15
<211> 1548
<212> DNA
<213> Artificial Sequence
<220>
<223> synthetic Ch1amyEPSPS/GRG23(ace3)(R173K) construct
<400> 15
atgaaggccc tgcgaagtgg aaccgctgtg gcgcggggcc aagcgggctg tgtttctccc 60
gctccgcgcc ctgtgcctat gtcgtctcag gcgatgattc cgagcaccag ctccccagca 120
gctcgtgcac ccgcccggtc cggtcgccgc gccctcgctg tgtcggccaa gctggctgat 180
gggtctcgtc gcatgcagtc cgaggaggtg cgccgcgcca aggaggtggc ccaggctgcg 240
ctggccaagg acagccctgc cgactgggtg gaccgctacg gctcggagcc gcgcaaggga 300
tccggcatgg aaactgatcg ccttgtgatc ccaggatcga aaagcatcac caaccgggct 360
ttgcttttgg ctgccgcagc gaagggcacg tcggtcctgg tgagaccatt ggtcagcgcc 420
gatacctcag cattcaaaac tgcaatccag gccctcggtg ccaacgtctc agccgacggt 480
gacgattggg tcgttgaagg cctgggtcag gcacccaacc tcgacgccga catctggtgc 540
gaggacgcag gtactgtggc ccggttcctc cctccattcg tagccgcagg tcaggggaag 600
ttcaccgtcg acggatcaga gcagctgcgg cggcgcccgc ttcggcccgt ggtcgacggc 660
atccgccacc tgggcgcccg cgtctcctcc gagcagctgc cccttacaat tgaagcgagc 720
gggctggcag gcggggagta cgaaattgaa gcccatcaga gcagccagtt cgcctccggc 780
ctgatcatgg ccgccccgta cgcgagacaa ggcctgcgtg tgcggatacc aaatcccgtg 840
tcacagccct acctcacgat gacactgcgg atgatgaggg acttcggcat tgagaccagc 900
accgacggag ccaccgtcag cgtccctcca gggcgctaca cagcccggcg gtatgaaata 960
gaaccggatg cgtcaactgc gtcgtacttc gccgccgctt ccgccgtctc tggcaggcgc 1020
ttcgaatttc aaggccttgg cacagacagc atccaaggcg acacgtcatt cttcaatgta 1080
cttgggcggc tcggtgcgga ggtccactgg gcatccaact cggtcaccat acggggaccg 1140
gaaaggctga ccggcgacat tgaagtggat atgggcgaga tttcggacac cttcatgaca 1200
ctcgcggcga ttgccccttt ggccgatgga cccatcacga taaccaacat tggtcatgca 1260
cggttgaagg aatccgaccg catctcagcg atggaaagca acctgcgcac gctcggtgta 1320
caaaccgacg tcggacacga ctggatgaga atctacccct ctaccccgca cggcggtaga 1380
gtgaattgcc accgggacca caggatcgct atggcgtttt caatcctggg actgagagtg 1440
gacgggatta ccctcgacga ccctcaatgc gtcgggaaga cctttcctgg cttcttcgac 1500
taccttggac gccttttccc cgaaaaggcg cttacgctcc ccggctag 1548
<210> 16
<211> 515
<212> PRT
<213> Artificial Sequence
<220>
<223> synthetic ChlamyEPSPS/GRG23(ace3)(R173K) construct
34i
CA 02736244 2011-03-04
<400> 16
Met Lys Ala Leu Arg Ser Gly Thr Ala Val Ala Arg Gly Gln Ala Gly
1 5 10 15
Cys Val Ser Pro Ala Pro Arg Pro Val Pro Met Ser Ser Gln Ala Met
20 25 30
Ile Pro Ser Thr Ser Ser Pro Ala Ala Arg Ala Pro Ala Arg Ser Gly
35 40 45
Arg Arg Ala Leu Ala Val Ser Ala Lys Leu Ala Asp Gly Ser Arg Arg
50 55 60
Met Gln Ser Glu Glu Val Arg Arg Ala Lys Glu Val Ala Gln Ala Ala
65 70 75 80
Leu Ala Lys Asp Ser Pro Ala Asp Trp Val Asp Arg Tyr Gly Ser Glu
85 90 95
Pro Arg Lys Gly Ser Gly Met Glu Thr Asp Arg Leu Val Ile Pro Gly
100 105 110
Ser Lys Ser Ile Thr Asn Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys
115 120 125
Gly Thr Ser Val Leu Val Arg Pro Leu Val Ser Ala Asp Thr Ser Ala
130 135 140
Phe Lys Thr Ala Ile Gln Ala Leu Gly Ala Asn Val Ser Ala Asp Gly
145 150 155 160
Asp Asp Trp Val Val Glu Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala
165 170 175
Asp Ile Trp Cys Glu Asp Ala Gly Thr Val Ala Arg Phe Leu Pro Pro
180 185 190
Phe Val Ala Ala Gly Gln Gly Lys Phe Thr Val Asp Gly Ser Glu Gln
195 200 205
Leu Arg Arg Arg Pro Leu Arg Pro Val Val Asp Gly Ile Arg His Leu
210 215 220
Gly Ala Arg Val Ser Ser Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser
225 230 235 240
Gly Leu Ala Gly Gly Glu Tyr Glu Ile Glu Ala His Gln Ser Ser Gln
245 250 255
Phe Ala Ser Gly Leu Ile Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu
260 265 270
Arg Val Arg Ile Pro Asn Pro Val Ser Gln Pro Tyr Leu Thr Met Thr
275 280 285
Leu Arg Met Met Arg Asp Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala
290 295 300
Thr Val Ser Val Pro Pro Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile
305 310 315 320
Glu Pro Asp Ala Ser Thr Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val
325 330 335
Ser Gly Arg Arg Phe Glu Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln
340 345 350
Gly Asp Thr Ser Phe Phe Asn Val Leu Gly Arg Leu Gly Ala Glu Val
355 360 365
His Trp Ala Ser Asn Ser Val Thr Ile Arg Gly Pro Glu Arg Leu Thr
370 375 380
Gly Asp Ile Glu Val Asp Met Gly Glu Ile Ser Asp Thr Phe Met Thr
385 390 395 400
Leu Ala Ala Ile Ala Pro Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn
405 410 415
Ile Gly His Ala Arg Leu Lys Glu Ser Asp Arg Ile Ser Ala Met Glu
420 425 430
Ser Asn Leu Arg Thr Leu Gly Val Gln Thr Asp Val Gly His Asp Trp
435 440 445
Met Arg Ile Tyr Pro Ser Thr Pro His Gly Gly Arg Val Asn Cys His
450 455 460
Arg Asp His Arg Ile Ala Met Ala Phe Ser Ile Leu Gly Leu Arg Val
465 470 475 480
Asp Gly Ile Thr Leu Asp Asp Pro Gln Cys Val Gly Lys Thr Phe Pro
485 490 495
34j
CA 02736244 2011-03-04
Gly Phe Phe Asp Tyr Leu Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr
500 505 510
Leu Pro Gly
515
<210> 17
<211> 4
<212> PRT
<213> Artificial Sequence
<220>
<223> stromal targeting domain
<220>
<221> VARIANT
<222> 1
<223> Xaa = Ile or Val
<220>
<221> VARIANT
<222> 2
<223> Xaa = any amino acid
<220>
<221> VARIANT
<222> 3
<223> Xaa = Ala or Cys
<400> 17
Xaa Xaa Xaa Ala
1
<210> 18
<211> 3
<212> PRT
<213> Artificial Sequence
<220>
<223> linker sequence
<400> 18
Gly Ser Gly
1
34k
